Gene	"Gene synonym"	Ensembl	"Gene description"	Uniprot	Chromosome	Position	"Protein class"	"Biological process"	"Molecular function"	"Disease involvement"	Evidence	"HPA evidence"	"UniProt evidence"	"NeXtProt evidence"	"RNA tissue specificity"	"RNA tissue distribution"	"RNA tissue specificity score"	"RNA tissue specific nTPM"	"RNA single cell type specificity"	"RNA single cell type distribution"	"RNA single cell type specificity score"	"RNA single cell type specific nTPM"	"RNA cancer specificity"	"RNA cancer distribution"	"RNA cancer specificity score"	"RNA cancer specific FPKM"	"RNA brain regional specificity"	"RNA brain regional distribution"	"RNA brain regional specificity score"	"RNA brain regional specific nTPM"	"RNA blood cell specificity"	"RNA blood cell distribution"	"RNA blood cell specificity score"	"RNA blood cell specific nTPM"	"RNA blood lineage specificity"	"RNA blood lineage distribution"	"RNA blood lineage specificity score"	"RNA blood lineage specific nTPM"	"RNA cell line specificity"	"RNA cell line distribution"	"RNA cell line specificity score"	"RNA cell line specific nTPM"	"RNA mouse brain regional specificity"	"RNA mouse brain regional distribution"	"RNA mouse brain regional specificity score"	"RNA mouse brain regional specific nTPM"	"RNA pig brain regional specificity"	"RNA pig brain regional distribution"	"RNA pig brain regional specificity score"	"RNA pig brain regional specific nTPM"	Antibody	"Reliability (IH)"	"Reliability (Mouse Brain)"	"Reliability (IF)"	"Subcellular location"	"Secretome location"	"CCD Protein"	"CCD Transcript"	"Blood concentration - Conc. blood IM [pg/L]"	"Blood concentration - Conc. blood MS [pg/L]"	"Blood expression cluster"	"Tissue expression cluster"	"Cell line expression cluster"	"Single cell expression cluster"	"Subcellular main location"	"Subcellular additional location"	"Antibody RRID"	"Pathology prognostics - Breast cancer"	"Pathology prognostics - Cervical cancer"	"Pathology prognostics - Colorectal cancer"	"Pathology prognostics - Endometrial cancer"	"Pathology prognostics - Glioma"	"Pathology prognostics - Head and neck cancer"	"Pathology prognostics - Liver cancer"	"Pathology prognostics - Lung cancer"	"Pathology prognostics - Melanoma"	"Pathology prognostics - Ovarian cancer"	"Pathology prognostics - Pancreatic cancer"	"Pathology prognostics - Prostate cancer"	"Pathology prognostics - Renal cancer"	"Pathology prognostics - Stomach cancer"	"Pathology prognostics - Testis cancer"	"Pathology prognostics - Thyroid cancer"	"Pathology prognostics - Urothelial cancer"	"Tissue RNA - adipose tissue [nTPM]"	"Tissue RNA - adrenal gland [nTPM]"	"Tissue RNA - amygdala [nTPM]"	"Tissue RNA - appendix [nTPM]"	"Tissue RNA - basal ganglia [nTPM]"	"Tissue RNA - bone marrow [nTPM]"	"Tissue RNA - breast [nTPM]"	"Tissue RNA - cerebellum [nTPM]"	"Tissue RNA - cerebral cortex [nTPM]"	"Tissue RNA - cervix [nTPM]"	"Tissue RNA - choroid plexus [nTPM]"	"Tissue RNA - colon [nTPM]"	"Tissue RNA - duodenum [nTPM]"	"Tissue RNA - endometrium 1 [nTPM]"	"Tissue RNA - epididymis [nTPM]"	"Tissue RNA - esophagus [nTPM]"	"Tissue RNA - fallopian tube [nTPM]"	"Tissue RNA - gallbladder [nTPM]"	"Tissue RNA - heart muscle [nTPM]"	"Tissue RNA - hippocampal formation [nTPM]"	"Tissue RNA - hypothalamus [nTPM]"	"Tissue RNA - kidney [nTPM]"	"Tissue RNA - liver [nTPM]"	"Tissue RNA - lung [nTPM]"	"Tissue RNA - lymph node [nTPM]"	"Tissue RNA - medulla oblongata [nTPM]"	"Tissue RNA - midbrain [nTPM]"	"Tissue RNA - ovary [nTPM]"	"Tissue RNA - pancreas [nTPM]"	"Tissue RNA - parathyroid gland [nTPM]"	"Tissue RNA - pituitary gland [nTPM]"	"Tissue RNA - placenta [nTPM]"	"Tissue RNA - pons [nTPM]"	"Tissue RNA - prostate [nTPM]"	"Tissue RNA - rectum [nTPM]"	"Tissue RNA - retina [nTPM]"	"Tissue RNA - salivary gland [nTPM]"	"Tissue RNA - seminal vesicle [nTPM]"	"Tissue RNA - skeletal muscle [nTPM]"	"Tissue RNA - skin 1 [nTPM]"	"Tissue RNA - small intestine [nTPM]"	"Tissue RNA - smooth muscle [nTPM]"	"Tissue RNA - spinal cord [nTPM]"	"Tissue RNA - spleen [nTPM]"	"Tissue RNA - stomach 1 [nTPM]"	"Tissue RNA - testis [nTPM]"	"Tissue RNA - thalamus [nTPM]"	"Tissue RNA - thymus [nTPM]"	"Tissue RNA - thyroid gland [nTPM]"	"Tissue RNA - tongue [nTPM]"	"Tissue RNA - tonsil [nTPM]"	"Tissue RNA - urinary bladder [nTPM]"	"Tissue RNA - vagina [nTPM]"	"Tissue RNA - white matter [nTPM]"	"Cell RNA - A-431 [nTPM]"	"Cell RNA - A549 [nTPM]"	"Cell RNA - AF22 [nTPM]"	"Cell RNA - AN3-CA [nTPM]"	"Cell RNA - ASC diff [nTPM]"	"Cell RNA - ASC TERT1 [nTPM]"	"Cell RNA - BEWO [nTPM]"	"Cell RNA - BJ [nTPM]"	"Cell RNA - BJ hTERT+ [nTPM]"	"Cell RNA - BJ hTERT+ SV40 Large T+ [nTPM]"	"Cell RNA - BJ hTERT+ SV40 Large T+ RasG12V [nTPM]"	"Cell RNA - CACO-2 [nTPM]"	"Cell RNA - CAPAN-2 [nTPM]"	"Cell RNA - Daudi [nTPM]"	"Cell RNA - EFO-21 [nTPM]"	"Cell RNA - fHDF/TERT166 [nTPM]"	"Cell RNA - GAMG [nTPM]"	"Cell RNA - HaCaT [nTPM]"	"Cell RNA - HAP1 [nTPM]"	"Cell RNA - HBEC3-KT [nTPM]"	"Cell RNA - HBF TERT88 [nTPM]"	"Cell RNA - HDLM-2 [nTPM]"	"Cell RNA - HEK 293 [nTPM]"	"Cell RNA - HEL [nTPM]"	"Cell RNA - HeLa [nTPM]"	"Cell RNA - Hep G2 [nTPM]"	"Cell RNA - HHSteC [nTPM]"	"Cell RNA - HL-60 [nTPM]"	"Cell RNA - HMC-1 [nTPM]"	"Cell RNA - HSkMC [nTPM]"	"Cell RNA - hTCEpi [nTPM]"	"Cell RNA - hTEC/SVTERT24-B [nTPM]"	"Cell RNA - hTERT-HME1 [nTPM]"	"Cell RNA - hTERT-RPE1 [nTPM]"	"Cell RNA - HUVEC TERT2 [nTPM]"	"Cell RNA - JURKAT [nTPM]"	"Cell RNA - K-562 [nTPM]"	"Cell RNA - Karpas-707 [nTPM]"	"Cell RNA - LHCN-M2 [nTPM]"	"Cell RNA - MCF7 [nTPM]"	"Cell RNA - MOLT-4 [nTPM]"	"Cell RNA - NB-4 [nTPM]"	"Cell RNA - NTERA-2 [nTPM]"	"Cell RNA - OE19 [nTPM]"	"Cell RNA - PC-3 [nTPM]"	"Cell RNA - REH [nTPM]"	"Cell RNA - RH-30 [nTPM]"	"Cell RNA - RPMI-8226 [nTPM]"	"Cell RNA - RPTEC TERT1 [nTPM]"	"Cell RNA - RT4 [nTPM]"	"Cell RNA - SCLC-21H [nTPM]"	"Cell RNA - SH-SY5Y [nTPM]"	"Cell RNA - SiHa [nTPM]"	"Cell RNA - SK-BR-3 [nTPM]"	"Cell RNA - SK-MEL-30 [nTPM]"	"Cell RNA - SuSa [nTPM]"	"Cell RNA - T-47d [nTPM]"	"Cell RNA - THP-1 [nTPM]"	"Cell RNA - TIME [nTPM]"	"Cell RNA - U-138 MG [nTPM]"	"Cell RNA - U-2 OS [nTPM]"	"Cell RNA - U-2197 [nTPM]"	"Cell RNA - U-251 MG [nTPM]"	"Cell RNA - U-266/70 [nTPM]"	"Cell RNA - U-266/84 [nTPM]"	"Cell RNA - U-698 [nTPM]"	"Cell RNA - U-87 MG [nTPM]"	"Cell RNA - U-937 [nTPM]"	"Cell RNA - WM-115 [nTPM]"	"Blood RNA - basophil [nTPM]"	"Blood RNA - classical monocyte [nTPM]"	"Blood RNA - eosinophil [nTPM]"	"Blood RNA - gdT-cell [nTPM]"	"Blood RNA - intermediate monocyte [nTPM]"	"Blood RNA - MAIT T-cell [nTPM]"	"Blood RNA - memory B-cell [nTPM]"	"Blood RNA - memory CD4 T-cell [nTPM]"	"Blood RNA - memory CD8 T-cell [nTPM]"	"Blood RNA - myeloid DC [nTPM]"	"Blood RNA - naive B-cell [nTPM]"	"Blood RNA - naive CD4 T-cell [nTPM]"	"Blood RNA - naive CD8 T-cell [nTPM]"	"Blood RNA - neutrophil [nTPM]"	"Blood RNA - NK-cell [nTPM]"	"Blood RNA - non-classical monocyte [nTPM]"	"Blood RNA - plasmacytoid DC [nTPM]"	"Blood RNA - T-reg [nTPM]"	"Blood RNA - total PBMC [nTPM]"	"Brain RNA - amygdala [nTPM]"	"Brain RNA - basal ganglia [nTPM]"	"Brain RNA - cerebellum [nTPM]"	"Brain RNA - cerebral cortex [nTPM]"	"Brain RNA - hippocampal formation [nTPM]"	"Brain RNA - hypothalamus [nTPM]"	"Brain RNA - medulla oblongata [nTPM]"	"Brain RNA - midbrain [nTPM]"	"Brain RNA - pons [nTPM]"	"Brain RNA - spinal cord [nTPM]"	"Brain RNA - thalamus [nTPM]"	"Brain RNA - white matter [nTPM]"	"Single Cell Type RNA - Adipocytes [nTPM]"	"Single Cell Type RNA - Alveolar cells type 1 [nTPM]"	"Single Cell Type RNA - Alveolar cells type 2 [nTPM]"	"Single Cell Type RNA - Astrocytes [nTPM]"	"Single Cell Type RNA - B-cells [nTPM]"	"Single Cell Type RNA - Basal keratinocytes [nTPM]"	"Single Cell Type RNA - Basal prostatic cells [nTPM]"	"Single Cell Type RNA - Basal respiratory cells [nTPM]"	"Single Cell Type RNA - Basal squamous epithelial cells [nTPM]"	"Single Cell Type RNA - Bipolar cells [nTPM]"	"Single Cell Type RNA - Breast glandular cells [nTPM]"	"Single Cell Type RNA - Breast myoepithelial cells [nTPM]"	"Single Cell Type RNA - Cardiomyocytes [nTPM]"	"Single Cell Type RNA - Cholangiocytes [nTPM]"	"Single Cell Type RNA - Club cells [nTPM]"	"Single Cell Type RNA - Collecting duct cells [nTPM]"	"Single Cell Type RNA - Cone photoreceptor cells [nTPM]"	"Single Cell Type RNA - Cytotrophoblasts [nTPM]"	"Single Cell Type RNA - dendritic cells [nTPM]"	"Single Cell Type RNA - Distal enterocytes [nTPM]"	"Single Cell Type RNA - Distal tubular cells [nTPM]"	"Single Cell Type RNA - Ductal cells [nTPM]"	"Single Cell Type RNA - Early spermatids [nTPM]"	"Single Cell Type RNA - Endometrial ciliated cells [nTPM]"	"Single Cell Type RNA - Endometrial stromal cells [nTPM]"	"Single Cell Type RNA - Endothelial cells [nTPM]"	"Single Cell Type RNA - Enteroendocrine cells [nTPM]"	"Single Cell Type RNA - Erythroid cells [nTPM]"	"Single Cell Type RNA - Excitatory neurons [nTPM]"	"Single Cell Type RNA - Exocrine glandular cells [nTPM]"	"Single Cell Type RNA - Extravillous trophoblasts [nTPM]"	"Single Cell Type RNA - Fibroblasts [nTPM]"	"Single Cell Type RNA - Gastric mucus-secreting cells [nTPM]"	"Single Cell Type RNA - Glandular and luminal cells [nTPM]"	"Single Cell Type RNA - granulocytes [nTPM]"	"Single Cell Type RNA - Granulosa cells [nTPM]"	"Single Cell Type RNA - Hepatic stellate cells [nTPM]"	"Single Cell Type RNA - Hepatocytes [nTPM]"	"Single Cell Type RNA - Hofbauer cells [nTPM]"	"Single Cell Type RNA - Horizontal cells [nTPM]"	"Single Cell Type RNA - Inhibitory neurons [nTPM]"	"Single Cell Type RNA - Intestinal goblet cells [nTPM]"	"Single Cell Type RNA - Ionocytes [nTPM]"	"Single Cell Type RNA - Kupffer cells [nTPM]"	"Single Cell Type RNA - Langerhans cells [nTPM]"	"Single Cell Type RNA - Late spermatids [nTPM]"	"Single Cell Type RNA - Leydig cells [nTPM]"	"Single Cell Type RNA - Macrophages [nTPM]"	"Single Cell Type RNA - Melanocytes [nTPM]"	"Single Cell Type RNA - Microglial cells [nTPM]"	"Single Cell Type RNA - monocytes [nTPM]"	"Single Cell Type RNA - Muller glia cells [nTPM]"	"Single Cell Type RNA - NK-cells [nTPM]"	"Single Cell Type RNA - Oligodendrocyte precursor cells [nTPM]"	"Single Cell Type RNA - Oligodendrocytes [nTPM]"	"Single Cell Type RNA - Pancreatic endocrine cells [nTPM]"	"Single Cell Type RNA - Paneth cells [nTPM]"	"Single Cell Type RNA - Peritubular cells [nTPM]"	"Single Cell Type RNA - Plasma cells [nTPM]"	"Single Cell Type RNA - Prostatic glandular cells [nTPM]"	"Single Cell Type RNA - Proximal enterocytes [nTPM]"	"Single Cell Type RNA - Proximal tubular cells [nTPM]"	"Single Cell Type RNA - Respiratory ciliated cells [nTPM]"	"Single Cell Type RNA - Rod photoreceptor cells [nTPM]"	"Single Cell Type RNA - Sertoli cells [nTPM]"	"Single Cell Type RNA - Skeletal myocytes [nTPM]"	"Single Cell Type RNA - Smooth muscle cells [nTPM]"	"Single Cell Type RNA - Spermatocytes [nTPM]"	"Single Cell Type RNA - Spermatogonia [nTPM]"	"Single Cell Type RNA - Squamous epithelial cells [nTPM]"	"Single Cell Type RNA - Suprabasal keratinocytes [nTPM]"	"Single Cell Type RNA - Syncytiotrophoblasts [nTPM]"	"Single Cell Type RNA - T-cells [nTPM]"	"Single Cell Type RNA - Theca cells [nTPM]"	"Single Cell Type RNA - Undifferentiated cells [nTPM]"	"Single Cell Type RNA - Urothelial cells [nTPM]"
ACSS1	"ACAS2L, AceCS2L, dJ568C11.3, MGC33843"	ENSG00000154930	"Acyl-CoA synthetase short chain family member 1"	Q9NUB1	20	25006230-25058980	"Enzymes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins"		Ligase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Astrocytes: 300.4;Cytotrophoblasts: 329.7;Syncytiotrophoblasts: 419.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"Hep G2: 50.3;JURKAT: 51.2;MOLT-4: 49.6;OE19: 64.6;RPMI-8226: 75.1;U-937: 51.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041014, HPA043228"	Enhanced					NA	NA			"Cluster 15: NK-cells - Transcription"	"Cluster 22: Non-specific - Unknown function"	"Cluster 21: OE19 - Mitochondria"	"Cluster 47: Cytotrophoblasts - Unknown function"			"HPA041014: AB_2677251, HPA043228: AB_2678372"	"unprognostic (6.87e-2)"	"prognostic favorable (9.37e-4)"	"unprognostic (5.32e-2)"	"unprognostic (1.54e-1)"	"unprognostic (2.78e-1)"	"unprognostic (3.03e-2)"	"unprognostic (3.20e-3)"	"prognostic favorable (8.33e-5)"	"unprognostic (2.44e-1)"	"unprognostic (2.17e-2)"	"unprognostic (2.43e-1)"	"unprognostic (7.72e-2)"	"unprognostic (4.58e-3)"	"unprognostic (5.85e-2)"	"unprognostic (2.68e-1)"	"unprognostic (3.69e-1)"	"unprognostic (1.60e-1)"	12.8	9.5	65.0	15.5	70.2	33.4	14.1	55.8	66.9	16.1	124.7	28.1	49.3	16.1	19.7	14.3	18.8	15.0	91.3	64.5	55.7	49.9	13.9	20.2	25.5	57.9	65.0	22.6	57.4	34.0	11.3	118.4	53.8	29.1	20.6	4.0	39.8	12.0	44.6	18.0	46.8	13.1	53.4	33.6	62.9	38.6	67.7	30.9	29.8	41.4	21.3	15.7	14.5	60.8	0.1	11.8	3.4	0.0	10.6	4.0	0.2	1.3	5.1	5.0	3.3	12.0	1.6	21.0	2.0	4.8	21.5	5.9	17.1	2.6	1.0	0.0	1.6	36.0	0.2	50.3	11.1	8.5	0.4	7.0	8.6	0.5	0.0	0.0	10.9	51.2	1.9	39.0	0.4	1.3	49.6	14.6	0.2	64.6	18.9	38.2	1.1	75.1	7.3	9.4	8.3	0.2	2.3	4.6	33.5	0.2	22.5	19.1	1.7	0.1	0.1	0.1	0.6	26.7	1.9	0.0	0.5	51.5	13.0	5.6	2.8	7.2	4.2	5.1	3.3	4.0	2.7	3.6	3.5	5.1	2.3	3.5	0.5	10.2	3.4	2.1	2.7	2.3	65.0	70.2	55.8	66.9	64.5	55.7	57.9	65.0	53.8	53.4	67.7	60.8	10.8	12.8	15.1	300.4	29.8	5.2	6.7	3.1	5.2	2.2	15.1	8.0	73.0	45.8	7.7	11.0	0.0	329.7	26.4	27.2	76.3	6.5	87.7	14.3	5.0	9.7	0.0	42.9	0.9	7.7	10.9	14.0	26.5	7.2	5.7	20.4	9.3	6.2	53.2	0.0	1.8	28.5	10.2	11.2	8.8	16.2	34.5	12.0	7.2	41.2	12.3	14.8	25.7	32.2	31.4	1.9	15.8	32.4	42.2	14.0	90.6	16.7	13.8	1.0	19.7	8.8	12.0	1.1	2.0	9.5	4.3	419.5	22.6	60.2	23.4	4.1
ALDOB		ENSG00000136872	"Aldolase, fructose-bisphosphate B"	P05062	9	101420560-101449664	"Cancer-related genes, Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	Glycolysis	Lyase	"Cancer-related genes, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	27	"intestine: 5736.6;kidney: 7181.0;liver: 11160.8"	"Group enriched"	"Detected in some"	4	"Proximal enterocytes: 20078.3;Proximal tubular cells: 7956.0"	"Cancer enriched"	"Detected in many"	31	"liver cancer: 1414.0"	"Low region specificity"	"Detected in some"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"BEWO: 21.4;NB-4: 21.0;RPMI-8226: 28.6;SH-SY5Y: 20.6"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			"HPA002198, CAB020827"	Enhanced					NA	NA		560000000		"Cluster 41: Intestine & Liver - Lipid metabolism"	"Cluster 24: NB-4 - Immune response"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"			"CAB020827: , HPA002198: AB_1078129"	"unprognostic (6.58e-3)"	"unprognostic (2.83e-1)"	"unprognostic (1.43e-3)"	"unprognostic (1.03e-1)"	"unprognostic (8.10e-2)"	"unprognostic (1.96e-2)"	"unprognostic (1.44e-3)"	"unprognostic (4.34e-2)"	"unprognostic (4.57e-2)"	"unprognostic (2.66e-1)"	"unprognostic (5.79e-2)"	"unprognostic (7.48e-2)"	"unprognostic (1.66e-2)"	"unprognostic (2.02e-1)"	"unprognostic (2.58e-1)"	"unprognostic (5.19e-2)"	"unprognostic (1.96e-2)"	3.3	1.4	0.4	17.0	0.7	0.0	0.7	1.0	2.3	0.2	0.0	30.1	4073.8	2.8	1.0	0.7	0.4	176.9	1.0	2.4	0.0	7181.0	11160.8	0.5	4.9	0.0	0.0	0.5	292.7	0.0	5.6	0.4	0.0	2.1	5.6	0.3	0.3	0.0	0.4	0.5	5736.6	7.0	0.0	2.0	34.3	1.1	0.0	0.7	0.3	0.0	0.8	0.1	0.3	0.3	0.0	0.0	0.1	0.0	0.0	0.0	21.4	0.0	0.0	0.0	0.0	0.5	0.0	4.5	1.8	0.0	0.0	0.6	0.0	0.0	0.0	0.4	0.0	2.2	0.0	1.0	0.0	6.1	0.4	0.0	0.0	0.0	0.0	0.1	0.0	0.0	1.0	0.3	0.0	0.0	0.3	21.0	0.4	0.5	0.0	0.3	4.6	28.6	0.0	0.0	4.3	20.6	2.0	0.0	0.0	0.0	0.0	0.1	1.9	0.1	1.0	7.1	0.3	0.5	0.7	2.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.7	1.0	2.3	2.4	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.3	39.4	0.0	0.0	0.3	0.0	1.1	0.0	0.0	1.1	308.8	0.8	150.8	0.0	0.0	0.0	13.5	620.3	4.9	0.0	0.0	0.4	3.6	0.0	50.8	0.5	253.3	0.1	0.0	0.0	0.3	0.0	0.0	49.2	3225.4	0.2	3.3	0.2	464.9	0.0	66.2	0.0	0.0	0.0	38.1	0.0	0.0	3.6	0.3	0.0	0.0	0.3	182.1	997.4	0.0	0.1	0.0	20078.3	7956.0	0.2	0.6	0.0	0.4	1.6	0.0	0.0	0.0	0.0	0.3	20.6	0.2	412.7	0.0
CCKBR		ENSG00000110148	"Cholecystokinin B receptor"	P32239	11	6259806-6272127	"Cancer-related genes, FDA approved drug targets, G-protein coupled receptors, Predicted intracellular proteins, Predicted membrane proteins"		"G-protein coupled receptor, Receptor, Transducer"	"Cancer-related genes, FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	29	"brain: 14.1;pancreas: 27.1;stomach 1: 42.0"	"Group enriched"	"Detected in some"	4	"Excitatory neurons: 14.6;Gastric mucus-secreting cells: 14.3;Granulosa cells: 23.3"	"Cancer enriched"	"Detected in some"	8	"testis cancer: 9.6"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	7	"NTERA-2: 73.4"	"Low region specificity"	"Detected in many"													NA	NA				"Cluster 22: Non-specific - Unknown function"	"Cluster 5: NTERA-2 - Transcription"	"Cluster 40: Granulosa cells - Unknown function"				"unprognostic (2.82e-1)"			"unprognostic (4.62e-2)"	"unprognostic (1.79e-3)"	"unprognostic (2.19e-1)"		"unprognostic (1.95e-1)"	"unprognostic (6.34e-4)"	"unprognostic (8.01e-2)"	"unprognostic (3.01e-2)"	"unprognostic (9.00e-2)"	"unprognostic (3.30e-2)"	"unprognostic (2.06e-1)"	"unprognostic (2.92e-1)"	"unprognostic (1.30e-2)"		0.1	0.2	8.2	0.0	11.7	0.0	0.0	6.3	14.1	0.0	0.3	0.2	0.3	0.3	0.0	0.0	0.3	0.0	0.0	11.9	1.7	0.0	0.0	0.0	0.0	3.7	1.8	0.1	27.1	0.0	0.9	0.0	3.8	0.5	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	1.3	0.0	42.0	0.5	2.6	0.0	0.2	0.0	0.0	0.0	0.0	6.6	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	8.4	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.0	0.0	0.0	0.0	0.0	0.0	0.0	73.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.5	0.0	0.0	0.0	0.0	10.5	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.2	11.7	6.3	14.1	11.9	1.7	3.7	1.8	3.8	1.3	2.6	6.6	0.0	0.0	0.0	0.7	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.1	0.0	0.0	14.6	1.3	0.0	0.2	14.3	0.1	0.0	23.3	0.0	0.0	0.1	0.0	4.0	0.0	0.0	0.0	0.3	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	1.5	0.7	0.3	0.0	0.0	0.0	0.1	0.0	0.0	0.7	0.0	0.0	0.0	0.1	0.7	1.5	0.0	0.0	0.3	0.0	0.0	0.0	0.0
CCNJL	FLJ14166	ENSG00000135083	"Cyclin J like"	Q8IV13	5	160249083-160345396	"Predicted intracellular proteins"		Cyclin		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 18.6"	"Cell type enhanced"	"Detected in many"		"Alveolar cells type 1: 22.4;Alveolar cells type 2: 23.4;Intestinal goblet cells: 28.5;Paneth cells: 26.8"	"Low cancer specificity"	"Detected in many"			"Region enhanced"	"Detected in all"		"cerebellum: 18.6"	"Group enriched"	"Detected in some"	17	"neutrophil: 12.7;NK-cell: 4.2"	"Group enriched"	"Detected in many"	85	"granulocytes: 12.7;NK-cells: 4.2"	"Cell line enhanced"	"Detected in many"		"HBEC3-KT: 49.8;RT4: 28.0;WM-115: 38.3"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA049970	Approved		Approved	"Nuclear speckles"		NA	NA			"Cluster 9: Neutrophils - Innate immune response"	"Cluster 21: Non-specific - Transcription"	"Cluster 17: WM-115 - Nervous system development"	"Cluster 27: Mucus-secreting cells - Mucin production"	"Nuclear speckles"		"HPA049970: AB_2680974"	"unprognostic (1.09e-2)"	"unprognostic (2.36e-2)"	"prognostic favorable (7.31e-4)"	"unprognostic (1.50e-3)"	"unprognostic (1.79e-1)"	"unprognostic (4.31e-2)"	"unprognostic (1.60e-4)"	"unprognostic (1.26e-2)"	"unprognostic (6.92e-2)"	"unprognostic (3.09e-1)"	"unprognostic (2.57e-1)"	"unprognostic (1.75e-2)"	"unprognostic (6.27e-3)"	"unprognostic (6.63e-3)"	"unprognostic (2.62e-1)"	"prognostic favorable (7.10e-4)"	"prognostic favorable (8.02e-4)"	0.9	3.8	1.2	1.6	1.2	1.4	1.3	18.6	3.1	2.6	1.3	7.8	1.3	0.7	0.6	1.0	1.3	0.7	5.7	4.7	1.2	4.0	0.7	7.8	0.4	1.8	2.0	5.4	0.2	0.1	3.8	0.9	2.1	1.4	5.8	1.5	4.8	1.3	0.2	0.5	3.3	0.8	1.4	7.5	7.2	12.2	2.2	2.6	4.2	2.6	1.1	3.4	1.5	1.3	3.9	20.8	16.4	0.2	0.0	0.0	0.0	0.0	0.3	1.9	0.8	7.9	16.8	0.0	13.2	0.2	13.9	5.9	2.3	49.8	1.3	0.0	0.3	6.0	7.3	6.8	0.2	0.0	0.2	0.0	4.2	2.7	11.9	9.9	12.7	5.8	0.1	0.0	5.3	2.7	0.0	12.1	11.5	0.0	7.8	3.4	4.6	1.7	12.6	28.0	4.7	10.5	2.9	3.7	17.1	6.2	9.9	1.1	14.9	2.6	13.8	0.0	9.8	0.0	0.0	0.0	0.0	0.0	38.3	0.3	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	12.7	4.2	0.0	0.0	0.0	0.2	1.2	1.2	18.6	3.1	4.7	1.2	1.8	2.0	2.1	1.4	2.2	1.3	0.6	22.4	23.4	9.4	0.0	0.3	1.8	3.8	0.0	0.7	1.0	2.3	4.8	0.0	6.8	3.7	0.0	0.0	4.5	4.4	5.9	2.7	1.0	0.5	1.4	2.6	2.4	0.0	0.7	0.2	0.0	1.2	1.1	1.4	1.3	11.5	2.2	0.2	0.1	0.0	9.3	28.5	8.2	0.3	0.3	3.6	2.1	2.1	5.4	2.8	0.6	8.3	14.4	1.5	0.7	1.7	26.8	2.6	0.5	1.3	4.3	0.2	1.5	0.1	0.0	0.7	1.9	0.5	10.0	0.4	0.4	0.0	2.2	11.2	4.6	2.4
CYB5R1	"humb5R2, NQO3A2"	ENSG00000159348	"Cytochrome b5 reductase 1"	Q9UHQ9	1	202961873-202967275	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Lipid biosynthesis, Lipid metabolism, Steroid biosynthesis, Steroid metabolism, Sterol biosynthesis, Sterol metabolism"	Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 605.2"	"Cell type enhanced"	"Detected in all"		"Basal keratinocytes: 187.2;Extravillous trophoblasts: 196.5;Syncytiotrophoblasts: 293.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"HaCaT: 187.3;hTCEpi: 188.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA010641, HPA014147"	Enhanced		Approved	Mitochondria,Cytosol		NA	NA			"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 38: Extravillous trophoblasts - Unknown function"	Mitochondria	Cytosol	"HPA010641: AB_1078600, HPA014147: AB_1847370"	"unprognostic (6.36e-2)"	"unprognostic (8.51e-2)"	"unprognostic (1.16e-2)"	"prognostic favorable (1.14e-4)"	"unprognostic (1.86e-2)"	"unprognostic (4.34e-2)"	"unprognostic (8.46e-2)"	"unprognostic (1.28e-1)"	"unprognostic (4.03e-1)"	"unprognostic (1.03e-1)"	"unprognostic (5.79e-2)"	"unprognostic (2.89e-1)"	"unprognostic (1.73e-2)"	"unprognostic (2.33e-1)"	"unprognostic (6.14e-2)"	"unprognostic (2.37e-3)"	"unprognostic (1.69e-1)"	38.6	57.3	37.4	23.0	38.8	19.7	43.7	41.1	40.5	49.7	57.3	35.7	19.3	41.2	131.4	61.6	68.2	27.2	154.8	38.3	48.0	64.5	50.2	44.0	25.2	45.4	49.4	41.7	45.1	82.9	46.1	66.6	55.7	41.1	21.2	34.3	56.9	40.0	605.2	123.8	25.7	37.5	39.9	39.1	92.8	50.7	41.4	40.1	40.5	308.0	38.8	52.7	45.8	43.6	34.8	21.3	18.3	37.7	166.0	37.9	178.5	68.3	63.4	43.2	38.4	17.5	39.9	21.5	56.5	68.1	24.0	187.3	14.9	58.0	28.2	31.2	37.8	12.4	24.0	20.4	59.7	10.5	29.6	61.2	188.3	47.5	25.8	36.4	28.9	25.8	37.0	37.6	157.8	40.4	13.6	9.5	12.1	31.0	40.1	21.9	87.6	45.7	41.1	40.8	15.7	19.1	38.0	124.0	57.4	39.4	57.7	23.4	28.5	49.0	20.8	18.7	38.3	34.9	44.5	10.0	53.6	16.2	37.1	24.4	56.7	46.6	27.4	42.6	36.3	23.4	30.9	28.9	37.6	35.0	41.9	29.6	46.0	32.2	29.4	25.9	34.2	52.6	37.4	38.8	41.1	40.5	38.3	48.0	45.4	49.4	55.7	39.9	41.4	43.6	33.0	22.4	29.8	10.1	15.5	187.2	38.5	89.5	42.1	21.0	46.1	41.9	119.3	37.1	60.5	29.5	29.2	171.1	15.8	10.6	7.9	38.3	5.0	58.7	17.3	30.0	19.2	30.7	8.9	48.3	196.5	28.9	31.6	34.9	28.5	13.6	32.9	44.6	63.5	10.1	11.3	10.8	105.8	45.4	29.7	8.6	29.8	39.5	64.0	8.4	20.9	65.9	11.3	11.6	8.1	72.8	11.3	31.2	12.5	25.8	16.0	38.9	75.9	35.0	13.1	49.1	30.0	23.0	4.3	40.6	157.4	293.5	19.5	27.9	14.7	48.2
ENPP5		ENSG00000112796	"Ectonucleotide pyrophosphatase/phosphodiesterase family member 5"	Q9UJA9	6	46159185-46170980	"Predicted membrane proteins"		Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"epididymis: 243.6"	"Cell type enhanced"	"Detected in many"		"Muller glia cells: 100.1;Respiratory ciliated cells: 47.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"gdT-cell: 14.9"	"Lineage enriched"	"Detected in many"	5	"T-cells: 14.9"	"Cell line enhanced"	"Detected in some"		"CAPAN-2: 11.1;HSkMC: 7.1;SuSa: 6.2;T-47d: 8.7;U-266/84: 7.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA016902	Enhanced		Approved	Nucleoplasm,Cytosol	"Intracellular and membrane"	NA	NA		620000	"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 68: Epididymis - Unknown function"	"Cluster 29: U-266 - Adaptive immune response"	"Cluster 5: Muller glia cells - Visual perception"	Cytosol	Nucleoplasm	"HPA016902: AB_1848172"	"unprognostic (1.12e-1)"	"unprognostic (5.19e-2)"	"unprognostic (1.98e-1)"	"unprognostic (1.32e-1)"	"unprognostic (7.61e-2)"	"unprognostic (1.63e-1)"	"unprognostic (5.01e-2)"	"prognostic favorable (4.57e-4)"	"unprognostic (1.96e-1)"	"unprognostic (9.89e-2)"	"prognostic favorable (4.04e-4)"	"unprognostic (7.00e-2)"	"prognostic favorable (4.44e-13)"	"unprognostic (4.40e-2)"	"unprognostic (2.78e-2)"	"unprognostic (1.61e-1)"	"unprognostic (1.60e-1)"	1.8	8.6	6.2	1.1	7.6	0.2	13.4	6.9	12.6	12.8	4.0	2.6	1.5	1.8	243.6	1.8	15.4	7.0	4.4	7.0	9.7	24.3	0.5	8.8	1.2	5.8	13.0	9.7	9.7	46.3	19.8	1.7	6.2	29.4	3.2	30.6	14.4	31.0	10.7	1.6	1.9	0.9	4.5	5.7	6.7	35.5	14.0	8.2	51.0	10.3	1.4	5.6	1.8	6.3	0.0	0.0	0.0	0.0	0.0	0.0	4.3	0.0	0.0	0.5	0.1	0.3	11.1	1.8	3.6	0.2	3.7	0.0	0.6	1.5	0.1	0.0	2.4	0.7	0.0	0.0	0.0	0.0	0.0	7.1	0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.0	0.4	1.9	0.0	0.5	2.3	5.4	0.0	0.0	0.2	0.2	4.5	0.6	4.7	0.2	0.0	4.6	0.0	6.2	8.7	0.0	0.0	0.0	1.2	0.0	0.1	5.3	7.9	0.0	2.8	0.0	0.1	0.0	0.0	0.0	14.9	0.1	8.0	0.5	3.0	9.7	0.0	0.8	0.9	8.7	1.1	2.8	0.0	0.0	0.0	3.2	6.2	7.6	6.9	12.6	7.0	9.7	5.8	13.0	6.2	4.5	14.0	6.3	0.4	12.8	12.2	16.3	1.6	0.9	4.8	0.5	1.2	10.6	18.1	10.8	7.5	8.6	6.1	23.9	4.2	4.9	4.2	1.9	1.9	11.6	0.7	15.3	0.8	0.4	8.3	0.0	24.6	7.5	2.9	4.2	2.0	5.4	4.5	4.0	0.4	0.1	0.4	10.1	14.5	2.8	2.0	0.0	0.4	3.8	2.8	0.5	0.0	1.9	0.6	100.1	23.7	9.0	10.5	2.2	2.3	12.0	0.1	12.0	1.7	16.3	47.3	3.4	6.6	25.7	1.8	0.5	2.4	1.1	0.6	0.3	3.2	21.2	2.9	3.3
ESRRG	"ERR-gamma, ERRg, NR3B3"	ENSG00000196482	"Estrogen related receptor gamma"	P62508	1	216503246-217137755	"FDA approved drug targets, Nuclear receptors, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding, Receptor"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 49.6;parathyroid gland: 46.3;retina: 36.1;stomach 1: 35.1"	"Group enriched"	"Detected in many"	4	"Astrocytes: 330.7;Excitatory neurons: 415.2;Inhibitory neurons: 495.5;Oligodendrocyte precursor cells: 391.6;Oligodendrocytes: 218.7;Syncytiotrophoblasts: 214.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	4	"RPMI-8226: 23.0;SH-SY5Y: 42.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA044678	Uncertain		Approved	Nucleoplasm		No	NA				"Cluster 48: Parathyroid gland - membrane proteins"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	Nucleoplasm		"HPA044678: AB_10963215"	"unprognostic (6.48e-2)"	"unprognostic (1.11e-1)"	"unprognostic (7.06e-2)"	"unprognostic (7.32e-2)"	"unprognostic (2.34e-1)"	"unprognostic (5.48e-2)"	"unprognostic (1.66e-1)"	"unprognostic (1.13e-1)"	"unprognostic (4.55e-2)"	"unprognostic (2.88e-1)"	"unprognostic (2.35e-1)"	"unprognostic (1.79e-2)"	"prognostic favorable (1.13e-11)"	"unprognostic (3.04e-1)"	"unprognostic (2.55e-1)"	"unprognostic (3.65e-4)"	"unprognostic (2.05e-1)"	0.4	6.4	1.1	0.2	3.1	0.0	3.6	16.9	12.3	1.5	7.4	0.5	5.3	0.4	0.9	1.6	2.5	0.7	10.6	4.4	2.3	29.0	0.7	0.5	0.2	45.4	4.9	0.7	5.7	46.3	1.5	10.6	49.6	3.1	0.3	36.1	16.0	0.7	5.8	0.8	5.0	0.2	1.6	1.1	35.1	1.1	3.5	0.6	5.9	10.2	0.3	0.7	0.2	6.1	0.3	0.0	0.8	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	1.3	0.1	0.0	0.0	0.0	0.0	0.0	3.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	1.2	0.0	0.2	0.0	0.0	23.0	3.4	2.5	8.1	42.4	0.0	0.4	0.0	2.5	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	1.1	3.1	16.9	12.3	4.4	2.3	45.4	4.9	49.6	1.6	3.5	6.1	0.2	0.0	1.8	330.7	0.2	0.3	3.8	0.6	0.6	29.5	9.5	5.2	51.2	10.0	1.8	23.9	58.4	35.4	0.0	0.0	54.8	5.0	5.1	15.9	2.0	1.3	8.3	0.0	415.2	2.4	4.7	3.0	70.3	3.5	0.0	0.5	1.1	0.6	4.8	48.8	495.5	1.7	14.2	0.3	0.4	8.1	0.3	0.5	8.8	36.5	0.0	13.3	0.0	391.6	218.7	0.4	1.3	0.7	0.1	4.9	16.3	29.0	16.0	41.3	0.0	10.3	0.4	1.6	0.3	0.8	0.3	214.9	0.3	1.1	2.6	1.7
ETNPPL	AGXT2L1	ENSG00000164089	"Ethanolamine-phosphate phospho-lyase"	Q8TBG4	4	108742048-108763054	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		Lyase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 155.6;liver: 191.1"	"Cell type enriched"	"Detected in some"	8	"Astrocytes: 219.4"	"Group enriched"	"Detected in some"	23	"glioma: 7.9;liver cancer: 21.7"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HeLa: 5.7;Hep G2: 2.3;NTERA-2: 1.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA044546, HPA072938"	Supported		Approved	Nucleoplasm		Yes	NA				"Cluster 15: Liver - Metabolism"	"Cluster 20: HeLa - Mitochondria"	"Cluster 64: Astrocytes - Nervous system maintenance"	Nucleoplasm		"HPA044546: AB_10962867, HPA072938: AB_2686560"	"unprognostic (5.20e-3)"	"unprognostic (1.33e-1)"		"unprognostic (3.93e-1)"	"prognostic favorable (9.52e-5)"		"unprognostic (5.93e-3)"	"unprognostic (3.91e-2)"	"unprognostic (2.82e-1)"	"unprognostic (6.32e-2)"	"unprognostic (2.70e-2)"	"unprognostic (1.30e-1)"	"unprognostic (3.40e-2)"	"unprognostic (1.93e-1)"	"unprognostic (1.59e-1)"	"unprognostic (1.42e-2)"	"unprognostic (9.48e-2)"	0.3	5.5	155.6	0.1	155.6	0.0	0.1	98.4	144.3	0.1	47.4	0.0	0.2	0.3	0.0	0.1	0.0	0.2	10.6	124.4	145.8	9.1	191.1	0.1	0.0	100.7	118.1	0.1	0.0	2.9	1.9	0.0	110.3	0.0	0.0	1.7	34.4	0.1	2.4	0.0	0.0	0.0	101.2	0.7	18.3	0.5	119.8	0.1	1.1	1.5	0.0	0.0	0.0	101.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.5	0.0	5.7	2.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	1.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.2	0.0	0.4	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	155.6	155.6	98.4	144.3	124.4	145.8	100.7	118.1	110.3	101.2	119.8	101.3	0.0	0.0	0.0	219.4	0.2	0.0	0.0	0.0	0.0	0.0	1.2	0.0	14.2	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.1	0.2	0.4	0.0	0.0	0.4	0.0	0.0	0.5	1.5	0.4	0.0	0.0	0.7	26.8	0.0	0.0	0.6	0.0	0.0	1.6	0.0	1.7	0.0	0.0	0.0	7.5	0.0	8.5	0.0	1.5	0.7	0.0	0.0	0.0	0.1	0.0	0.0	7.9	0.0	0.2	0.0	0.2	0.2	0.2	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.1
FGA		ENSG00000171560	"Fibrinogen alpha chain"	P02671	4	154583128-154590745	"Cancer-related genes, Candidate cardiovascular disease genes, Disease related genes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted secreted proteins"	"Adaptive immunity, Blood coagulation, Hemostasis, Immunity, Innate immunity"		"Amyloidosis, Cancer-related genes, Disease variant, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	388	"liver: 18396.9"	"Cell type enriched"	"Detected in some"	41	"Hepatocytes: 17365.8"	"Cancer enriched"	"Detected in many"	43	"liver cancer: 2431.6"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	15	"Hep G2: 429.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"CAB016776, HPA051370, HPA064755"	Supported		Enhanced	"Endoplasmic reticulum"	"Secreted to blood"	NA	NA	407000000	140000000000		"Cluster 62: Liver - Hemostasis"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 15: Hepatocytes - Hemostasis"	"Endoplasmic reticulum"		"CAB016776: , HPA051370: AB_2681458, HPA064755: AB_2685345"		"unprognostic (5.95e-2)"	"unprognostic (6.25e-2)"	"unprognostic (2.02e-1)"		"unprognostic (5.68e-2)"	"prognostic favorable (7.33e-4)"	"unprognostic (1.29e-3)"			"unprognostic (1.84e-1)"		"prognostic unfavorable (4.23e-6)"	"unprognostic (4.20e-1)"	"unprognostic (1.41e-1)"			2.1	1.3	0.0	0.0	0.0	0.0	1.0	0.0	0.0	1.5	0.0	0.5	0.0	0.6	0.6	0.7	0.9	13.2	1.2	0.0	0.0	18.8	18396.9	5.3	0.1	0.0	0.0	0.7	18.8	0.0	0.5	0.9	0.0	0.4	0.0	0.0	0.5	0.0	0.5	0.6	0.9	0.0	0.0	9.9	47.4	3.7	0.0	0.1	0.4	0.0	0.1	0.6	0.7	0.0	0.0	28.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	24.1	0.0	2.7	0.2	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	3.4	0.1	429.3	0.0	6.3	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.0	0.0	0.0	0.1	0.2	0.0	0.5	0.1	0.0	0.5	6.1	0.0	0.0	0.5	0.2	0.1	3.5	0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.3	0.0	0.0	1.0	0.0	1.9	0.0	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	20.4	0.0	27.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.5	414.6	3.2	0.0	0.0	0.0	0.0	0.0	1.9	38.6	28.3	0.1	0.2	8.1	0.0	205.9	0.0	1.8	0.1	0.1	1.1	1.3	0.0	0.0	238.8	17365.8	0.1	0.0	0.0	0.0	0.0	328.3	0.0	46.1	0.6	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	19.2	0.0	1.2	0.0	0.0	0.0	2.3	9.5	0.0	0.0	0.0	0.1	17.4	0.7	0.0	0.0	0.1	17.6	0.0	0.0	0.0
FNDC10	C1orf233	ENSG00000228594	"Fibronectin type III domain containing 10"	F2Z333	1	1598012-1600135	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adrenal gland: 25.4;brain: 24.4"	"Group enriched"	"Detected in some"	6	"Granulosa cells: 57.0;Theca cells: 46.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in single"		"eosinophil: 1.6"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"HMC-1: 27.8"	"Low region specificity"	"Detected in all"													NA	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 26: Pituitary gland - Hormone signaling"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 40: Granulosa cells - Unknown function"				"unprognostic (9.50e-2)"	"unprognostic (1.38e-1)"	"unprognostic (1.76e-1)"	"unprognostic (1.11e-1)"	"unprognostic (3.22e-2)"	"unprognostic (8.35e-2)"	"unprognostic (7.32e-3)"	"unprognostic (4.33e-2)"	"unprognostic (3.33e-1)"	"unprognostic (3.12e-1)"	"unprognostic (2.72e-2)"	"unprognostic (1.97e-1)"	"prognostic favorable (1.11e-4)"	"unprognostic (2.09e-2)"	"unprognostic (1.50e-1)"	"unprognostic (6.00e-2)"	"unprognostic (5.76e-2)"	1.5	25.4	11.0	1.5	11.4	2.6	1.4	11.2	24.4	2.3	6.2	1.5	2.1	1.1	0.0	9.5	0.8	2.2	3.0	12.6	22.0	3.7	0.5	2.3	1.0	20.6	17.8	1.8	0.9	7.4	10.9	1.0	19.0	0.9	0.5	0.6	2.2	0.4	0.3	10.0	1.6	0.6	10.0	3.1	2.9	8.3	14.3	0.3	5.2	0.3	0.8	1.2	3.7	12.9	0.0	4.1	3.9	12.1	7.9	1.8	5.5	9.6	1.9	15.1	0.8	3.7	17.2	0.0	11.2	4.7	0.1	2.5	0.9	2.1	1.3	0.0	3.5	0.2	4.1	9.1	1.8	3.0	27.8	2.6	9.5	0.7	0.1	1.8	1.0	11.0	8.0	0.0	1.8	18.7	2.3	9.1	16.6	5.8	5.9	0.0	0.0	9.7	5.4	0.9	17.9	14.8	10.2	15.1	10.6	2.5	0.0	9.3	1.6	0.0	2.9	6.5	0.0	2.9	0.3	0.2	0.0	6.2	4.3	0.0	0.7	1.6	0.1	0.5	0.1	0.0	0.3	0.3	0.7	0.0	0.3	0.2	0.0	0.0	0.7	0.0	0.3	0.2	11.0	11.4	11.2	24.4	12.6	22.0	20.6	17.8	19.0	10.0	14.3	12.9	0.3	0.0	2.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	6.9	8.5	0.0	0.0	0.0	0.0	0.0	0.2	1.7	0.0	3.9	1.3	0.0	2.4	3.0	0.5	0.0	0.0	0.0	0.9	2.5	2.4	0.0	4.7	0.0	57.0	0.0	0.0	5.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.0	0.6	0.0	0.0	0.0	0.0	2.2	0.0	0.0	0.3	0.0	0.0	0.6	0.0	0.0	0.0	0.0	2.1	0.0	0.0	0.0	0.0	0.1	0.6	46.3	0.0	0.0
GCNT2	"bA360O19.2, bA421M1.1, CCAT, GCNT5, IGNT, II, NACGT1, NAGCT1, ULG3"	ENSG00000111846	"Glucosaminyl (N-acetyl) transferase 2 (I blood group)"	Q8N0V5	6	10492223-10629368	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"		"Glycosyltransferase, Transferase"	"Cataract, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"prostate: 13.5"	"Cell type enhanced"	"Detected in many"		"Alveolar cells type 1: 76.9;Endometrial ciliated cells: 79.1;Glandular and luminal cells: 105.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Immune cell enhanced"	"Detected in some"		"basophil: 1.9"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"EFO-21: 44.2;Hep G2: 19.7;SK-MEL-30: 17.1;SuSa: 21.4"	"Region enriched"	"Detected in all"	4	"basal ganglia: 61.1"	"Low region specificity"	"Detected in all"			HPA026776	Approved		Approved	"Golgi apparatus"		No	No		750000	"Cluster 41: Basophils - Cellular respiration"	"Cluster 87: Intestine & Kidney - Transmembrane transport"	"Cluster 38: EFO-21 - Unknown function"	"Cluster 44: Endometrium - Transcription"	"Golgi apparatus"		"HPA026776: AB_1849573"	"unprognostic (2.47e-1)"	"unprognostic (6.87e-3)"	"unprognostic (3.12e-1)"	"unprognostic (1.42e-2)"	"unprognostic (9.31e-2)"	"unprognostic (2.51e-1)"	"unprognostic (4.11e-2)"	"unprognostic (2.39e-1)"	"unprognostic (1.27e-1)"	"unprognostic (2.11e-2)"	"unprognostic (6.28e-4)"	"unprognostic (3.96e-2)"	"unprognostic (1.58e-3)"	"unprognostic (6.54e-2)"	"unprognostic (6.32e-2)"	"unprognostic (1.13e-1)"	"unprognostic (1.53e-1)"	0.6	0.3	0.7	1.0	0.6	0.3	10.1	2.5	1.1	4.2	4.5	3.6	5.2	1.4	0.2	1.4	0.8	1.5	6.6	0.8	1.1	5.7	5.1	3.9	1.8	1.2	1.0	0.3	1.3	0.4	1.4	2.6	1.4	13.5	2.0	0.3	4.2	0.3	0.7	1.4	5.8	1.6	0.9	1.5	5.9	2.5	0.9	0.5	1.2	1.8	2.4	1.0	0.7	1.0	6.3	4.9	1.5	4.8	0.0	0.0	9.6	0.0	4.1	1.1	0.5	11.0	5.2	3.5	44.2	0.0	3.2	0.3	0.4	5.1	2.9	3.1	1.8	0.5	2.6	19.7	0.0	1.7	4.7	0.0	0.0	0.5	0.0	2.4	9.1	0.0	0.4	0.0	0.4	0.0	0.0	4.0	4.4	0.0	3.6	0.2	3.8	6.0	16.0	2.9	4.0	1.2	0.0	14.4	17.1	21.4	0.3	0.8	6.4	0.8	0.5	0.0	5.0	0.1	0.0	2.4	0.8	0.3	2.3	1.9	1.1	0.5	0.1	0.8	0.0	0.7	0.1	0.1	0.8	0.4	0.1	0.2	0.1	0.2	0.2	0.2	0.0	0.3	0.7	0.6	2.5	1.1	0.8	1.1	1.2	1.0	1.4	0.9	0.9	1.0	1.4	76.9	32.4	1.0	9.5	4.6	6.6	15.5	9.6	5.1	30.5	16.1	18.4	2.8	28.6	7.3	0.0	27.9	6.4	15.5	11.7	2.9	4.3	79.1	5.5	11.0	2.4	25.9	0.7	24.7	2.1	2.0	16.8	105.5	2.5	0.0	12.8	32.0	15.8	3.3	11.8	5.6	6.1	7.7	9.4	8.2	0.3	7.8	49.8	52.5	11.1	2.4	0.0	18.6	1.1	12.0	11.9	0.0	1.0	16.6	44.3	13.4	27.9	0.6	0.0	0.7	2.2	6.2	27.6	11.2	1.7	10.9	3.1	0.0	16.3	8.1
GRIA4	"GluA4, GLUR4, GLURD"	ENSG00000152578	"Glutamate ionotropic receptor AMPA type subunit 4"	P48058	11	105609994-105982092	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins"	"Ion transport, Transport"	"Ion channel, Ligand-gated ion channel, Receptor"	"Disease variant, Mental retardation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	12	"brain: 105.5;retina: 32.1"	"Group enriched"	"Detected in some"	5	"Excitatory neurons: 799.1;Horizontal cells: 471.1;Inhibitory neurons: 1045.0;Oligodendrocyte precursor cells: 755.5"	"Cancer enriched"	"Detected in some"	5	"glioma: 5.9"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AF22: 12.1;NTERA-2: 4.0;RPMI-8226: 2.4;SCLC-21H: 4.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"								"Intracellular and membrane"	NA	NA				"Cluster 69: Cerebellum - Gene expression regulation"	"Cluster 12: NES - Nervous system development"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"				"unprognostic (1.45e-1)"	"unprognostic (2.63e-1)"	"unprognostic (4.09e-4)"	"unprognostic (4.45e-3)"	"unprognostic (1.92e-3)"	"unprognostic (4.14e-4)"	"unprognostic (1.40e-2)"	"unprognostic (3.73e-4)"	"unprognostic (1.62e-1)"	"unprognostic (3.89e-1)"	"unprognostic (2.04e-1)"	"unprognostic (1.53e-1)"	"unprognostic (1.70e-1)"	"unprognostic (2.48e-1)"	"unprognostic (1.38e-1)"	"unprognostic (3.35e-2)"	"unprognostic (1.28e-1)"	0.1	5.6	5.3	0.5	20.7	0.0	3.1	105.5	32.2	1.4	0.0	1.5	0.0	0.5	1.6	0.0	1.0	0.2	0.1	27.7	21.4	0.5	0.0	0.0	0.6	30.5	24.2	0.2	0.8	0.0	2.3	0.3	36.7	0.2	0.9	32.1	3.0	0.4	0.1	0.5	3.2	0.0	21.0	0.0	5.7	0.1	18.9	0.0	0.1	0.0	0.4	0.0	0.1	19.0	0.0	0.0	12.1	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	4.0	0.0	0.1	0.0	0.0	2.4	0.0	0.0	4.3	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.3	20.7	105.5	32.2	27.7	21.4	30.5	24.2	36.7	21.0	18.9	19.0	0.0	0.0	0.0	36.9	0.0	0.1	0.0	0.0	0.0	48.2	0.9	7.4	1.2	0.0	0.0	0.0	2.1	0.0	0.0	0.0	0.0	0.2	0.8	0.0	2.2	0.4	0.0	0.0	799.1	0.0	0.0	1.2	0.5	0.1	0.0	0.0	0.0	0.0	1.1	471.1	1045.0	3.7	0.0	0.0	0.4	0.2	0.6	0.0	0.0	100.2	0.0	20.4	0.0	755.5	129.9	0.0	0.0	0.0	0.0	0.0	9.1	0.9	0.0	8.9	0.0	1.6	0.2	0.0	0.3	0.0	0.1	0.3	0.1	0.0	5.2	0.0
GUCA1C	GCAP3	ENSG00000138472	"Guanylate cyclase activator 1C"	O95843	3	108907792-108953879	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	7	"retina: 296.7"	"Cell type enriched"	"Detected in some"	4	"Cone photoreceptor cells: 125.1"	"Cancer enriched"	"Detected in single"	7	"pancreatic cancer: 0.5"	"Low region specificity"	"Detected in single"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	85	"RPTEC TERT1: 14.0"									HPA041597	Uncertain		Approved	"Focal adhesion sites"		NA	NA				"Cluster 79: Retina - Phototransduction"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 9: Photoreceptor cells - Phototransduction"	"Focal adhesion sites"		"HPA041597: AB_10795501"						"unprognostic (7.56e-2)"					"unprognostic (6.56e-2)"							0.0	0.0	0.3	0.0	0.3	0.0	0.0	0.0	0.3	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	15.5	1.0	0.8	0.8	0.0	0.0	0.0	0.0	0.0	0.4	41.5	0.0	0.4	0.0	0.1	0.0	0.0	296.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.3	1.3	0.1	0.0	0.0	0.0	0.0	4.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	14.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.3	0.0	0.3	1.0	0.8	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	7.7	0.0	0.0	14.5	0.0	0.0	0.0	125.1	0.0	0.0	0.0	0.0	0.0	11.5	0.0	0.0	0.3	0.0	0.0	0.7	0.6	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.5	0.0	0.0	0.0	0.0	10.2	0.0	0.0	0.0	1.0	0.0	9.7	0.0	0.0	0.5	0.3	0.0	0.0	0.0	0.0	0.0	0.1	0.0	29.6	0.0	0.0	0.0	1.5	0.1	0.0	0.0	0.0	0.0	17.5	0.0	0.0
HRH2		ENSG00000113749	"Histamine receptor H2"	P25021	5	175658030-175710756	"FDA approved drug targets, G-protein coupled receptors, Predicted membrane proteins"		"G-protein coupled receptor, Receptor, Transducer"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 37.0;heart muscle: 26.3"	"Cell type enhanced"	"Detected in many"		"Cardiomyocytes: 26.2;Excitatory neurons: 62.2;Inhibitory neurons: 19.1;Kupffer cells: 29.4;Macrophages: 36.2;monocytes: 24.3;Smooth muscle cells: 33.6"	"Group enriched"	"Detected in many"	5	"melanoma: 2.9;renal cancer: 4.6"	"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"basophil: 134.4;neutrophil: 161.7"	"Group enriched"	"Detected in many"	5	"granulocytes: 161.7;monocytes: 51.6"	"Group enriched"	"Detected in some"	4	"RPMI-8226: 65.6;SK-MEL-30: 19.2;THP-1: 18.0;U-937: 21.6"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA013770	Approved					NA	NA			"Cluster 6: Non-specific - Transcription"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 25: RPMI-8226 - Immune response"	"Cluster 19: Monocytes & Neutrophils - Innate immune response"			"HPA013770: AB_1851086"	"unprognostic (8.56e-3)"	"unprognostic (1.62e-1)"	"unprognostic (6.66e-2)"	"unprognostic (5.96e-2)"	"unprognostic (3.49e-2)"	"unprognostic (1.80e-1)"	"unprognostic (1.20e-1)"	"unprognostic (4.77e-2)"	"unprognostic (9.93e-2)"	"unprognostic (5.76e-2)"	"unprognostic (1.52e-1)"	"unprognostic (2.35e-1)"	"unprognostic (3.71e-3)"	"unprognostic (2.01e-2)"	"unprognostic (1.97e-2)"	"unprognostic (1.97e-3)"	"unprognostic (1.77e-2)"	7.6	1.5	4.5	12.0	14.4	37.0	3.0	1.1	9.6	5.1	0.5	1.4	6.2	2.2	0.9	1.4	2.9	2.5	26.3	5.3	1.4	2.3	1.0	7.2	3.8	1.2	1.6	1.1	1.5	1.3	0.8	10.2	1.1	4.7	1.1	0.3	1.4	4.6	0.8	2.2	6.4	3.6	1.7	18.0	19.5	0.5	3.9	8.5	1.5	1.5	3.1	4.1	2.0	5.1	0.0	1.5	0.5	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	2.1	0.0	0.8	0.0	0.0	0.1	0.0	0.0	0.0	1.9	0.0	0.3	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.1	5.0	2.9	0.0	0.0	7.1	0.0	65.6	0.0	0.3	0.5	0.0	0.0	0.0	19.2	1.7	0.1	18.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	21.6	4.3	134.4	45.8	52.8	0.2	44.9	0.3	0.0	3.8	1.0	23.5	0.1	7.9	4.8	161.7	2.1	51.6	18.3	3.3	15.3	4.5	14.4	1.1	9.6	5.3	1.4	1.2	1.6	1.1	1.7	3.9	5.1	1.1	0.0	2.5	1.0	1.0	0.8	0.1	0.0	0.6	9.3	3.7	0.9	26.2	0.0	2.5	0.0	0.0	0.1	8.4	0.0	0.0	0.0	0.6	0.1	0.8	1.9	0.0	3.0	62.2	2.4	0.2	3.3	7.1	0.1	2.5	3.0	0.0	0.2	11.8	1.7	19.1	0.6	0.0	29.4	8.5	1.0	0.0	36.2	0.0	10.3	24.3	0.1	0.0	1.5	1.7	0.3	0.0	0.4	0.3	0.2	0.6	0.3	0.7	0.2	0.0	0.1	33.6	0.2	0.9	0.1	0.3	0.0	4.7	0.1	0.5	0.0
IGFBP2	IBP2	ENSG00000115457	"Insulin like growth factor binding protein 2"	P18065	2	216632828-216664436	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Growth regulation"	"Growth factor binding"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"pancreas: 956.0"	"Cell type enhanced"	"Detected in many"		"Endometrial stromal cells: 1379.1;Granulosa cells: 1649.7;Hepatocytes: 658.6;Theca cells: 2199.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"ASC diff: 2139.8;HMC-1: 5110.0;NB-4: 1106.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA077723			Approved	"Endoplasmic reticulum"	"Secreted to blood"	NA	NA	303000000	810000000	"Cluster 48: NK-cells - Unknown function"	"Cluster 29: Non-specific - Vesicular transport"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 40: Granulosa cells - Unknown function"	"Endoplasmic reticulum"		"HPA077723: AB_2686853"	"unprognostic (2.58e-1)"	"unprognostic (5.95e-2)"	"unprognostic (1.94e-1)"	"unprognostic (3.32e-3)"	"unprognostic (9.50e-3)"	"unprognostic (2.36e-2)"	"unprognostic (2.06e-1)"	"unprognostic (9.11e-3)"	"prognostic unfavorable (2.43e-4)"	"unprognostic (2.34e-1)"	"unprognostic (1.63e-3)"	"unprognostic (1.82e-1)"	"prognostic unfavorable (2.22e-5)"	"unprognostic (5.04e-2)"	"unprognostic (1.07e-1)"	"unprognostic (5.83e-2)"	"unprognostic (1.22e-1)"	219.5	58.8	15.9	28.3	14.8	21.4	90.5	15.6	30.2	86.9	123.3	85.5	76.8	232.5	59.9	145.6	157.0	26.9	169.2	15.6	16.3	187.3	607.7	71.0	8.8	15.3	21.7	281.7	956.0	12.4	66.9	81.0	19.3	217.3	35.0	2.4	76.4	196.2	23.3	30.8	44.6	49.7	13.2	398.9	492.2	58.0	16.0	33.6	57.8	21.9	14.5	132.6	97.4	13.2	0.1	52.3	402.1	396.3	2139.8	652.9	8.5	125.2	61.9	6.1	0.6	1.2	1.5	0.1	171.7	0.8	15.2	11.5	145.4	156.9	0.6	0.8	84.9	91.3	0.2	26.3	53.3	38.6	5110.0	219.3	15.8	2.5	7.1	12.5	0.2	184.7	3.9	11.7	2.8	103.1	162.8	1106.5	437.4	98.2	4.8	139.2	9.1	2.0	2.0	117.1	84.1	443.4	0.3	3.4	2.6	362.2	332.4	67.3	0.5	1.6	2.4	1.6	6.2	6.2	0.9	9.7	6.0	177.4	478.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.1	15.9	14.8	15.6	30.2	15.6	16.3	15.3	21.7	19.3	13.2	16.0	13.2	354.3	3.2	0.6	2.0	3.3	13.8	534.0	238.2	19.4	0.2	79.0	498.0	12.5	11.5	40.1	264.8	2.1	1.8	5.4	86.4	29.4	3.0	1.0	153.2	1379.1	149.2	321.0	31.1	4.5	128.4	7.7	296.7	411.8	176.0	4.5	1649.7	92.1	658.6	5.3	0.0	0.8	191.6	54.9	24.1	5.0	4.9	5.6	21.8	3.6	13.1	1.3	3.6	3.1	1.0	1.0	60.7	51.3	79.4	0.4	255.7	4.2	1.2	195.9	1.7	105.2	17.9	435.7	6.0	35.8	103.3	5.5	2.2	16.0	2199.1	133.8	304.0
KCNJ10	"Kir1.2, Kir4.1"	ENSG00000177807	"Potassium inwardly rectifying channel subfamily J member 10"	P78508	1	159998651-160070160	"Disease related genes, FDA approved drug targets, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters, Voltage-gated ion channels"	"Ion transport, Potassium transport, Transport"	"Ion channel, Voltage-gated channel"	"Deafness, Disease variant, Epilepsy, FDA approved drug targets, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	5	"brain: 100.7;kidney: 28.0;retina: 36.7"	"Group enriched"	"Detected in some"	5	"Astrocytes: 93.0;Muller glia cells: 75.7;Oligodendrocyte precursor cells: 35.7;Oligodendrocytes: 93.7"	"Cancer enriched"	"Detected in some"	6	"glioma: 27.4"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"Hep G2: 6.7;SK-MEL-30: 2.1;U-266/70: 2.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA078302	Enhanced					NA	NA			"Cluster 35: T-regs - Unknown function"	"Cluster 70: Brain - Nervous system development"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 5: Muller glia cells - Visual perception"			"HPA078302: AB_2732378"	"unprognostic (2.64e-2)"	"unprognostic (3.54e-3)"	"unprognostic (6.19e-2)"	"unprognostic (1.33e-1)"	"unprognostic (2.84e-1)"	"unprognostic (6.98e-4)"	"unprognostic (1.96e-1)"	"unprognostic (7.13e-2)"	"unprognostic (3.43e-1)"	"unprognostic (1.28e-3)"	"unprognostic (5.80e-4)"	"unprognostic (9.52e-2)"	"unprognostic (2.09e-2)"	"unprognostic (2.08e-2)"	"unprognostic (1.41e-1)"	"unprognostic (3.77e-1)"	"unprognostic (6.70e-3)"	0.1	0.3	56.7	2.1	86.3	0.0	0.1	100.2	58.4	0.2	8.7	0.5	0.2	0.1	0.0	0.1	0.1	0.1	0.1	51.4	78.7	28.0	2.1	0.1	7.3	92.7	94.7	0.1	0.1	0.1	0.4	0.0	87.5	0.2	0.2	36.7	0.3	0.2	0.1	0.4	0.5	0.0	71.8	10.5	0.9	0.6	83.6	0.4	0.2	0.1	1.9	0.1	0.1	100.7	0.0	0.0	0.1	0.0	0.0	0.2	0.1	0.0	0.0	0.1	0.2	0.0	0.1	1.0	0.1	0.0	0.6	0.2	0.1	0.0	0.1	0.0	0.1	0.0	0.0	6.7	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.5	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.1	0.3	0.0	1.2	0.1	0.0	0.0	0.1	0.2	0.0	0.1	2.1	0.5	0.0	0.3	0.1	0.0	0.2	0.5	0.0	2.0	1.0	0.0	0.1	0.1	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.4	0.0	0.4	0.0	0.0	0.6	0.0	56.7	86.3	100.2	58.4	51.4	78.7	92.7	94.7	87.5	71.8	83.6	100.7	0.1	0.0	0.0	93.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.3	0.5	0.0	0.0	3.7	4.2	0.0	0.0	0.0	11.7	0.0	0.4	0.0	0.0	0.1	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.2	0.0	0.4	0.0	0.0	13.0	0.0	1.1	0.0	1.1	0.0	3.7	0.0	75.7	0.0	35.7	93.7	0.0	0.0	0.0	0.3	0.0	0.0	0.3	0.0	3.5	0.0	0.1	0.1	0.4	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0
KCNJ13	"Kir1.4, Kir7.1, LCA16"	ENSG00000115474	"Potassium inwardly rectifying channel subfamily J member 13"	O60928	2	232765802-232776565	"Disease related genes, Human disease related genes, Potential drug targets, Predicted membrane proteins, Transporters, Voltage-gated ion channels"	"Ion transport, Potassium transport, Transport"	"Ion channel, Voltage-gated channel"	"Cataract, Disease variant, Leber congenital amaurosis"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	8	"choroid plexus: 159.5;intestine: 91.3"	"Group enriched"	"Detected in some"	4	"Muller glia cells: 54.8;Proximal enterocytes: 217.4;Undifferentiated cells: 68.1"	"Cancer enriched"	"Detected in some"	5	"melanoma: 5.9"	"Group enriched"	"Detected in many"	4	"cerebellum: 7.3;hippocampal formation: 8.0;thalamus: 5.3;white matter: 3.4"	"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in single"		"U-2197: 1.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA051609			Approved	"Nuclear membrane"		NA	NA			"Cluster 46: Basophils - DNA binding"	"Cluster 88: Choroid plexus - Transmembrane transport"	"Cluster 18: U-2197 - ECM organization"	"Cluster 45: Enterocytes - Digestion"	"Nuclear membrane"		"HPA051609: "	"unprognostic (4.29e-2)"	"unprognostic (2.00e-1)"	"unprognostic (2.69e-1)"	"unprognostic (9.03e-5)"	"unprognostic (1.17e-1)"	"unprognostic (3.12e-2)"		"unprognostic (2.26e-1)"	"unprognostic (3.44e-2)"	"unprognostic (1.40e-1)"	"unprognostic (1.41e-1)"	"unprognostic (4.90e-2)"	"unprognostic (1.86e-2)"	"unprognostic (2.04e-1)"	"unprognostic (1.65e-1)"	"unprognostic (1.82e-2)"	"unprognostic (1.11e-2)"	0.1	0.1	0.4	0.0	1.3	0.4	0.1	7.3	1.1	0.1	159.5	0.1	7.9	0.1	0.3	0.1	0.0	2.2	0.1	8.0	0.4	3.3	0.2	0.1	0.2	1.3	0.8	0.2	0.8	15.8	0.2	0.0	1.3	0.1	0.0	13.7	0.2	1.1	0.1	3.2	91.3	0.1	0.4	0.1	2.3	0.5	5.3	0.1	7.0	0.0	0.0	0.1	0.2	3.4	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.1	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.8	0.0	0.0	0.0	0.0	0.0	1.2	0.1	0.3	0.0	0.2	0.2	0.1	0.0	1.9	0.3	0.3	0.3	0.0	0.4	0.2	0.6	0.2	0.1	0.3	0.7	0.3	0.3	0.4	0.4	0.3	1.0	0.0	0.4	1.3	7.3	1.1	8.0	0.4	1.3	0.8	1.3	0.4	5.3	3.4	0.1	0.0	0.0	1.0	0.0	0.5	0.0	0.0	0.0	0.5	0.0	0.5	0.5	0.0	0.0	1.8	0.0	0.0	0.2	0.1	1.9	0.0	3.0	0.7	0.3	0.2	0.0	0.0	1.1	1.3	0.8	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	1.2	25.7	0.0	0.0	0.0	0.6	0.0	0.1	21.4	0.0	0.0	54.8	0.0	1.5	2.0	0.0	8.8	0.0	0.0	0.1	217.4	0.2	0.0	1.7	0.0	0.0	0.4	0.0	0.1	0.0	0.0	0.1	0.1	0.0	68.1	0.0
KCNQ1	"JLNS1, KCNA8, KCNA9, Kv7.1, KVLQT1, LQT, LQT1"	ENSG00000053918	"Potassium voltage-gated channel subfamily Q member 1"	P51787	11	2444684-2849105	"Disease related genes, FDA approved drug targets, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters, Voltage-gated ion channels"	"Ion transport, Potassium transport, Transport"	"Calmodulin-binding, Ion channel, Potassium channel, Voltage-gated channel"	"Atrial fibrillation, Deafness, Diabetes mellitus, Disease variant, FDA approved drug targets, Long QT syndrome, Short QT syndrome"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adrenal gland: 197.1;stomach 1: 98.9"	"Cell type enhanced"	"Detected in many"		"Granulosa cells: 47.6;Microglial cells: 71.2;Undifferentiated cells: 57.8"	"Cancer enhanced"	"Detected in all"		"colorectal cancer: 42.5"	"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"HMC-1: 33.4;OE19: 41.4;RPMI-8226: 23.2;U-266/70: 11.5;U-937: 13.4"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"CAB018656, HPA048553, HPA071107"	Enhanced		Supported	"Endoplasmic reticulum,Plasma membrane"		NA	NA			"Cluster 14: Monocytes - Unknown function"	"Cluster 29: Non-specific - Vesicular transport"	"Cluster 21: OE19 - Mitochondria"	"Cluster 53: Intestinal epithelial cells - Unknown function"	"Endoplasmic reticulum"	"Plasma membrane"	"CAB018656: AB_2131551, HPA048553: AB_2680438, HPA071107: "	"unprognostic (6.02e-2)"	"unprognostic (2.48e-1)"	"unprognostic (6.39e-3)"	"unprognostic (4.38e-1)"	"unprognostic (1.86e-1)"	"unprognostic (1.83e-1)"	"unprognostic (3.46e-2)"	"unprognostic (7.36e-2)"	"unprognostic (8.07e-2)"	"unprognostic (8.81e-2)"	"unprognostic (1.58e-1)"	"unprognostic (5.39e-2)"	"unprognostic (2.46e-3)"	"prognostic favorable (9.85e-4)"	"unprognostic (3.99e-2)"	"unprognostic (4.19e-2)"	"unprognostic (5.27e-2)"	5.4	197.1	2.1	9.0	2.4	14.2	3.0	2.4	2.6	16.5	5.7	22.6	47.8	2.9	14.1	2.9	8.9	19.5	28.4	2.6	2.6	25.3	1.8	15.9	5.0	4.1	3.1	1.4	61.2	21.4	5.5	7.6	3.9	6.1	15.2	0.7	20.0	50.2	1.0	1.2	39.7	3.1	4.0	8.2	98.9	1.6	4.2	3.6	71.6	1.6	2.9	14.7	1.6	4.4	0.0	0.1	0.0	5.8	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.6	2.6	1.9	5.2	0.0	0.4	0.1	0.7	0.0	0.0	0.4	1.3	0.0	3.7	0.4	0.3	0.0	33.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.4	0.0	0.7	0.0	0.7	1.3	41.4	0.2	0.1	0.0	23.2	8.0	2.7	0.7	5.6	0.7	0.0	0.0	0.5	0.2	10.3	0.0	0.0	0.3	0.2	0.0	11.5	0.0	0.0	0.0	13.4	0.0	0.7	3.1	3.1	0.0	1.8	0.0	0.8	0.4	0.1	3.8	0.3	1.0	1.2	3.3	0.0	2.8	1.3	0.3	1.0	2.1	2.4	2.4	2.6	2.6	2.6	4.1	3.1	3.9	4.0	4.2	4.4	7.1	3.2	12.9	0.3	8.4	0.6	8.0	4.2	0.0	1.7	6.1	1.8	18.6	14.3	7.1	29.5	0.0	1.1	0.3	34.0	15.6	23.2	2.0	3.3	0.4	6.3	6.6	0.4	13.7	21.7	1.4	1.0	23.4	4.9	19.7	47.6	9.3	1.1	17.3	0.0	20.0	26.1	8.2	25.4	15.9	0.9	0.3	19.6	1.8	71.2	11.0	0.5	1.0	43.7	34.9	15.3	20.2	0.0	6.4	5.2	30.9	2.0	4.4	0.5	6.6	0.4	1.7	0.2	0.2	0.1	1.0	2.1	4.0	16.6	57.8	20.4
KLHDC8A	FLJ10748	ENSG00000162873	"Kelch domain containing 8A"	Q8IYD2	1	205336061-205357090	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	11	"ovary: 284.0"	"Cell type enhanced"	"Detected in some"		"Bipolar cells: 50.8;Granulosa cells: 97.0;Muller glia cells: 19.8;Peritubular cells: 21.1;Theca cells: 44.6"	"Group enriched"	"Detected in many"	5	"glioma: 45.7;thyroid cancer: 14.5"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AF22: 4.2;HAP1: 8.7;NTERA-2: 2.1;SCLC-21H: 8.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"									NA	NA				"Cluster 89: Fibroblasts - ECM organization"	"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 40: Granulosa cells - Unknown function"				"unprognostic (1.58e-1)"	"unprognostic (1.25e-1)"	"unprognostic (4.18e-2)"	"unprognostic (4.80e-2)"	"unprognostic (3.43e-2)"	"unprognostic (3.21e-1)"	"unprognostic (2.63e-2)"	"unprognostic (2.97e-1)"	"unprognostic (4.92e-1)"	"unprognostic (8.37e-3)"	"unprognostic (7.39e-3)"	"unprognostic (4.03e-2)"	"unprognostic (1.84e-7)"	"unprognostic (4.53e-3)"	"unprognostic (5.83e-2)"	"prognostic favorable (8.01e-4)"	"unprognostic (1.20e-2)"	0.1	26.5	9.3	0.4	7.3	6.5	0.5	15.0	14.3	2.4	4.6	2.8	0.8	1.6	0.7	4.5	13.9	0.5	0.6	13.9	13.0	0.5	0.2	0.2	0.2	16.6	11.0	284.0	2.1	0.6	18.0	0.0	17.1	0.4	0.6	26.4	1.4	0.2	0.1	0.5	0.8	2.5	11.0	0.3	6.8	6.4	18.5	0.3	3.4	0.0	1.2	0.4	2.5	4.3	0.0	0.0	4.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.2	0.0	0.0	0.2	8.7	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	2.1	0.0	0.0	0.0	0.0	0.4	0.0	0.0	8.7	0.0	0.0	0.2	0.0	0.4	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.3	7.3	15.0	14.3	13.9	13.0	16.6	11.0	17.1	11.0	18.5	4.3	0.0	0.0	0.0	2.9	0.0	0.0	0.0	0.0	0.0	50.8	0.1	0.3	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.1	0.1	2.1	7.1	11.6	1.2	0.0	0.0	7.6	0.0	0.2	0.0	97.0	0.4	0.0	0.0	5.0	8.9	0.0	0.0	0.0	0.0	0.2	5.3	0.2	0.0	0.0	0.0	19.8	0.0	3.0	0.2	0.3	0.0	21.1	0.5	0.0	0.0	0.2	0.1	4.8	0.0	0.0	8.1	0.8	5.0	0.0	0.0	0.0	0.0	44.6	0.0	0.0
MPC1	"BRP44L, CGI-129, dJ68L15.3, SLC54A1"	ENSG00000060762	"Mitochondrial pyruvate carrier 1"	Q9Y5U8	6	166364919-166383013	"Disease related genes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	Transport		"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"heart muscle: 739.7;tongue: 559.2"	"Cell type enhanced"	"Detected in all"		"Cardiomyocytes: 950.0;Distal tubular cells: 1721.8;Proximal tubular cells: 573.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA045119, HPA055790"	Enhanced		Enhanced	Mitochondria		NA	NA			"Cluster 51: Monocytes - Innate immune response"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 21: OE19 - Mitochondria"	"Cluster 39: Non-specific - Basic cellular processes"	Mitochondria		"HPA045119: AB_10960421, HPA055790: AB_2682923"	"unprognostic (3.30e-2)"	"prognostic favorable (1.45e-4)"	"unprognostic (5.24e-3)"	"unprognostic (1.68e-1)"	"unprognostic (3.17e-2)"	"unprognostic (2.85e-2)"	"unprognostic (7.61e-2)"	"prognostic favorable (1.29e-4)"	"unprognostic (3.27e-1)"	"unprognostic (1.19e-1)"	"unprognostic (1.11e-3)"	"unprognostic (5.64e-2)"	"prognostic favorable (4.79e-11)"	"unprognostic (4.13e-2)"	"unprognostic (1.03e-1)"	"unprognostic (7.48e-2)"	"unprognostic (8.45e-2)"	61.7	39.6	105.9	33.4	119.5	57.0	52.8	129.7	153.1	52.4	108.0	97.7	84.8	35.7	44.8	71.5	34.7	41.7	739.7	101.2	127.8	259.9	411.2	44.6	44.3	119.2	123.9	43.4	66.0	141.8	38.1	23.7	119.5	43.5	89.9	57.3	87.7	42.3	319.4	40.9	63.8	38.5	117.1	35.0	96.1	22.2	121.5	48.6	82.9	559.2	44.2	47.4	34.9	132.4	25.6	7.5	31.3	107.7	88.4	49.8	45.2	29.1	47.1	45.1	43.9	38.8	17.9	53.6	50.9	45.4	36.1	24.5	47.0	36.7	31.9	36.1	79.0	27.5	35.4	132.6	36.6	104.9	34.1	40.0	51.0	36.8	26.7	13.7	36.9	80.8	94.2	84.1	28.6	40.5	73.1	193.7	16.1	148.0	35.5	39.1	51.7	134.9	85.4	20.5	96.7	85.7	33.6	145.8	34.0	25.9	34.5	154.3	25.3	25.7	26.8	91.6	30.0	55.8	42.2	46.3	23.5	127.0	42.1	60.7	60.0	90.1	41.7	98.3	39.4	33.1	48.5	45.1	72.2	25.4	44.7	43.3	54.6	40.5	128.5	43.0	69.1	49.8	105.9	119.5	129.7	153.1	101.2	127.8	119.2	123.9	119.5	117.1	121.5	132.4	56.1	118.6	48.0	64.6	51.7	45.6	44.2	83.6	29.0	61.1	74.2	79.1	950.0	187.3	67.6	106.7	10.4	22.0	54.2	219.1	1721.8	89.3	66.8	73.7	50.7	51.7	37.2	72.6	49.0	140.3	78.3	74.1	63.7	93.2	71.0	28.0	47.5	391.0	121.4	48.8	74.7	122.1	166.8	89.6	81.7	10.2	66.5	80.3	129.9	20.6	104.7	199.9	58.7	32.2	108.0	65.2	125.0	89.9	114.5	32.0	162.0	573.6	46.3	66.7	92.1	76.9	80.4	163.2	79.6	67.3	55.8	24.4	58.4	39.9	146.7	53.6
ODAM	"APin, FLJ20513"	ENSG00000109205	"Odontogenic, ameloblast associated"	A1E959	4	70196496-70204576	"Cancer-related genes, Predicted intracellular proteins"	Biomineralization		"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	38	"salivary gland: 371.5"	"Cell type enhanced"	"Detected in some"		"Alveolar cells type 2: 4.2;Breast glandular cells: 10.3;Ductal cells: 6.5;Exocrine glandular cells: 8.2;Gastric mucus-secreting cells: 6.6;Glandular and luminal cells: 10.5;Theca cells: 4.2"	"Low cancer specificity"	"Detected in many"			"Region enhanced"	"Detected in single"		"medulla oblongata: 1.2"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	15	"Hep G2: 31.7;OE19: 21.6"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			"HPA036279, HPA036543, HPA070297"			Supported	Nucleoplasm,Cytosol	"Intracellular and membrane"	NA	NA				"Cluster 24: Salivary gland - Salivary secretion"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 30: Mammary glandular cells - Lactation"	Nucleoplasm	Cytosol	"HPA036279: , HPA036543: AB_10669797, HPA070297: "	"unprognostic (2.34e-2)"	"unprognostic (2.43e-1)"	"unprognostic (1.26e-1)"	"unprognostic (1.75e-1)"		"unprognostic (3.34e-3)"	"unprognostic (1.06e-1)"	"unprognostic (1.88e-2)"		"unprognostic (3.47e-1)"	"unprognostic (3.08e-1)"	"unprognostic (3.03e-1)"		"unprognostic (2.72e-1)"		"unprognostic (1.86e-2)"	"unprognostic (2.50e-2)"	0.0	0.8	0.0	2.9	0.0	0.0	0.7	0.0	0.0	0.3	0.1	3.6	1.0	0.1	0.6	0.2	0.1	0.5	0.0	0.0	0.8	1.2	0.0	2.4	0.3	1.2	0.7	0.0	0.5	3.6	0.5	0.3	0.0	1.8	0.8	0.0	371.5	1.4	0.0	0.0	0.7	7.3	0.0	0.0	9.8	0.0	0.2	0.0	4.1	0.0	1.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	31.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	21.6	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.4	0.0	0.0	0.0	0.1	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	1.2	0.7	0.0	0.0	0.2	0.0	0.1	3.2	4.2	0.0	0.0	0.0	1.5	0.0	0.0	0.0	10.3	0.4	0.0	1.5	1.3	1.8	0.0	0.4	0.0	0.0	0.0	6.5	0.0	2.3	0.9	0.1	0.0	0.0	0.0	8.2	0.0	0.0	6.6	10.5	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.4	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.3	0.0	4.2	0.5	0.4
PIGN	"MCD4, PIG-N"	ENSG00000197563	"Phosphatidylinositol glycan anchor biosynthesis class N"	O95427	18	61905255-62187118	"Disease related genes, Human disease related genes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins"	"GPI-anchor biosynthesis"	Transferase	"Disease variant, Epilepsy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Alveolar cells type 1: 323.7;Alveolar cells type 2: 372.2;Club cells: 138.4;granulocytes: 159.0;Oligodendrocytes: 123.2;Respiratory ciliated cells: 145.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA039922, HPA040374"	Approved		Enhanced	"Plasma membrane,Cytosol"		NA	NA			"Cluster 33: Neutrophils - Chromatin organization"	"Cluster 6: Brain - Smell perception"	"Cluster 16: U-266 - Nucleosome"	"Cluster 11: Alveolar cells - Smell perception"	"Plasma membrane, Cytosol"		"HPA039922: AB_10805597, HPA040374: AB_10794738"	"unprognostic (1.93e-2)"	"unprognostic (1.71e-1)"	"prognostic favorable (6.51e-4)"	"unprognostic (1.03e-1)"	"unprognostic (9.99e-2)"	"unprognostic (3.99e-2)"	"unprognostic (1.23e-1)"	"unprognostic (3.99e-1)"	"unprognostic (1.64e-2)"	"unprognostic (1.75e-1)"	"unprognostic (1.15e-1)"	"unprognostic (2.81e-1)"	"unprognostic (1.78e-1)"	"unprognostic (6.59e-2)"	"unprognostic (1.08e-1)"	"unprognostic (5.75e-2)"	"unprognostic (2.71e-1)"	10.0	10.3	9.8	10.9	14.3	16.9	15.9	49.4	47.1	11.8	3.2	16.2	14.0	11.1	11.9	22.7	8.9	12.6	13.5	13.1	9.6	11.9	18.1	9.9	10.5	4.1	0.1	12.1	15.8	16.0	4.3	17.5	9.6	17.3	18.4	38.9	14.8	7.5	13.4	20.1	13.3	8.9	0.0	10.0	21.1	19.8	11.4	12.3	16.9	10.8	12.8	14.9	7.7	49.7	31.6	19.0	18.4	23.0	23.1	31.4	24.3	32.3	25.7	21.2	24.9	24.4	31.9	36.0	44.0	25.0	18.3	44.6	26.0	27.8	32.9	30.3	16.9	21.6	29.6	19.7	16.8	46.0	24.6	18.5	18.1	21.0	24.5	22.3	27.0	25.3	26.1	50.8	23.3	28.2	22.8	13.5	29.9	25.3	17.3	24.1	35.1	35.7	25.5	48.5	20.8	21.4	42.5	29.0	13.6	50.9	46.1	28.6	29.8	41.0	28.2	15.4	23.5	54.3	53.8	17.4	22.5	25.7	40.9	10.1	7.5	6.1	6.9	6.6	7.2	7.9	7.1	6.9	8.9	8.8	8.0	8.4	9.6	12.1	7.8	10.2	6.5	3.7	9.8	14.3	49.4	47.1	13.1	9.6	4.1	0.1	9.6	0.0	11.4	49.7	8.9	323.7	372.2	52.5	9.7	8.0	8.9	8.4	10.2	7.2	16.3	9.4	10.4	12.8	138.4	11.0	4.2	9.6	14.1	11.6	1.9	11.0	6.4	9.1	16.2	24.7	6.7	16.6	54.5	9.5	11.5	26.6	10.2	11.5	159.0	19.3	10.0	12.0	10.1	6.7	41.3	11.6	10.2	9.2	4.0	6.5	7.2	26.9	3.6	44.0	7.9	7.3	3.1	57.8	123.2	10.9	9.4	3.8	8.2	11.7	5.6	5.0	145.5	6.6	6.6	6.8	6.7	20.7	7.3	17.4	17.0	10.4	18.5	10.5	12.3	12.1
PPARGC1A	"PGC-1alpha, PGC1, PGC1A, PPARGC1"	ENSG00000109819	"PPARG coactivator 1 alpha"	Q9UBK2	4	23755041-23904089	"Cancer-related genes, Predicted intracellular proteins"	"Biological rhythms, Transcription, Transcription regulation"	"Activator, RNA-binding"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"liver: 44.6"	"Group enriched"	"Detected in many"	5	"Excitatory neurons: 1098.2;Inhibitory neurons: 1704.4;Oligodendrocyte precursor cells: 890.2"	"Cancer enhanced"	"Detected in many"		"renal cancer: 7.7"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	7	"A-431: 88.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA063136			Supported	Nucleoplasm		NA	NA				"Cluster 8: Non-specific - Mitochondria"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	Nucleoplasm		"HPA063136: AB_2684948"	"unprognostic (1.08e-1)"	"unprognostic (7.47e-2)"	"unprognostic (6.85e-3)"	"unprognostic (2.28e-6)"	"unprognostic (5.00e-2)"	"unprognostic (1.15e-1)"	"prognostic favorable (3.35e-6)"	"unprognostic (3.04e-1)"	"unprognostic (1.79e-1)"	"unprognostic (1.69e-1)"	"unprognostic (6.77e-2)"	"unprognostic (4.58e-2)"	"prognostic favorable (1.49e-14)"	"unprognostic (3.62e-2)"	"unprognostic (2.31e-1)"	"prognostic unfavorable (5.80e-4)"	"unprognostic (3.07e-3)"	2.3	2.9	4.2	0.6	3.2	0.0	1.6	7.6	13.0	3.3	33.9	7.4	7.6	0.9	1.5	3.3	1.5	2.6	36.3	3.1	10.7	29.0	44.6	3.1	0.2	4.1	4.1	1.2	3.8	38.5	4.8	0.1	2.6	3.3	9.1	4.2	29.3	3.0	29.5	8.2	6.6	1.9	2.4	0.8	4.3	4.5	7.2	2.3	17.7	37.2	0.4	1.1	1.0	4.1	88.6	0.0	1.6	0.0	2.6	0.0	0.0	0.0	1.9	0.2	0.2	0.0	0.0	0.2	0.0	0.0	0.2	0.1	0.3	0.0	0.0	0.0	0.8	0.0	4.5	10.7	0.0	0.1	0.0	8.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.6	0.2	0.0	0.0	0.0	0.4	7.6	0.0	0.0	0.7	0.0	12.3	0.1	4.0	0.2	2.8	0.0	3.5	4.2	0.5	1.4	0.0	0.7	0.7	0.0	1.6	8.1	0.1	0.1	1.6	1.4	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.2	3.2	7.6	13.0	3.1	10.7	4.1	4.1	2.6	2.4	7.2	4.1	2.5	19.2	2.6	240.6	0.9	0.9	4.1	7.4	1.2	7.0	2.7	1.5	90.9	47.1	6.3	36.8	39.6	0.0	0.0	36.0	52.8	12.0	78.3	7.2	1.3	0.8	26.7	0.0	1098.2	0.0	0.0	2.4	4.1	9.7	1.3	0.2	1.1	88.8	0.0	0.0	1704.4	17.0	38.7	2.5	0.3	69.7	0.9	0.6	7.2	24.4	0.1	6.4	0.0	890.2	28.8	0.6	7.3	2.2	1.8	1.4	32.0	26.8	4.8	1.9	0.0	37.1	5.1	0.8	0.6	2.6	1.1	0.0	1.0	1.9	21.9	1.5
PXMP2	"MPV17L3, PMP22"	ENSG00000176894	"Peroxisomal membrane protein 2"	Q9NR77	12	132687587-132704985	"Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 312.0"	"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 187.3;Hepatocytes: 577.4;Proximal enterocytes: 333.3;Proximal tubular cells: 303.7"	"Cancer enhanced"	"Detected in all"		"liver cancer: 43.8"	"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"									NA	NA			"Cluster 26: Non-specific - Mitochondria"	"Cluster 85: Liver - Metabolism"	"Cluster 14: REH - Unknown function"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"				"unprognostic (1.12e-2)"	"unprognostic (7.96e-2)"	"unprognostic (4.70e-3)"	"unprognostic (1.14e-1)"	"unprognostic (1.61e-1)"	"prognostic unfavorable (9.84e-4)"	"unprognostic (7.39e-3)"	"unprognostic (2.83e-1)"	"unprognostic (2.44e-2)"	"unprognostic (3.02e-1)"	"unprognostic (2.60e-1)"	"unprognostic (1.88e-1)"	"prognostic favorable (2.75e-4)"	"unprognostic (9.89e-2)"	"unprognostic (5.52e-2)"	"unprognostic (3.71e-3)"	"unprognostic (3.04e-1)"	24.8	14.7	23.7	7.5	24.3	23.4	18.7	24.5	29.8	14.3	37.7	49.5	52.1	14.9	22.3	16.2	18.7	15.4	62.9	28.5	24.1	58.2	312.0	12.9	11.5	24.1	24.2	23.0	42.5	14.5	9.3	8.1	22.9	19.8	39.2	7.5	18.6	9.7	42.3	16.8	55.1	9.5	23.0	13.1	98.2	9.1	24.9	25.9	14.7	30.5	10.7	15.9	12.8	23.5	60.5	24.8	36.6	34.1	21.5	16.6	21.4	21.0	19.4	44.7	39.6	30.3	22.4	37.2	24.9	30.0	15.7	42.0	49.1	26.6	24.3	21.3	77.8	33.2	43.9	33.8	41.7	24.8	14.4	21.7	21.8	18.6	14.7	31.2	12.1	56.2	58.2	28.4	23.8	54.2	78.9	39.2	35.7	70.0	33.9	80.1	39.2	30.6	32.9	25.2	69.0	22.5	45.6	23.6	29.6	28.1	63.2	56.0	14.3	21.9	51.1	19.1	35.6	25.7	26.7	60.6	24.6	34.9	17.7	0.0	1.2	2.9	2.3	0.6	2.1	2.5	1.8	2.4	2.1	2.7	1.8	1.5	0.7	1.5	0.6	6.3	3.1	1.2	23.7	24.3	24.5	29.8	28.5	24.1	24.1	24.2	22.9	23.0	24.9	23.5	10.9	3.2	7.2	8.1	8.2	8.4	20.0	10.6	15.4	6.1	50.3	51.1	35.8	138.7	6.0	25.8	4.2	60.1	7.3	187.3	166.3	16.5	18.7	11.8	16.9	14.1	18.7	55.9	5.9	10.3	36.6	17.0	65.7	17.4	4.5	32.4	46.8	577.4	34.9	0.0	7.1	85.1	2.0	19.2	9.4	38.8	31.1	8.1	12.4	5.6	2.7	45.5	13.4	4.5	1.0	10.2	143.4	35.0	20.9	28.1	333.3	303.7	2.1	7.3	19.7	7.5	14.8	44.9	30.2	31.2	10.7	28.5	8.1	12.4	158.6	23.2
RAP1GAP	"KIAA0474, RAP1GA1, RAP1GAP1, RAP1GAPII"	ENSG00000076864	"RAP1 GTPase activating protein"	P47736	1	21596215-21669363	"Predicted intracellular proteins"		"GTPase activation"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"kidney: 152.4;thyroid gland: 162.8"	"Cell type enhanced"	"Detected in many"		"Bipolar cells: 64.1;Distal tubular cells: 72.4;Excitatory neurons: 82.0;Horizontal cells: 92.5;Intestinal goblet cells: 112.6;Oligodendrocyte precursor cells: 51.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"A549: 46.3;OE19: 162.8;SCLC-21H: 52.1"	"Low region specificity"	"Detected in all"			"Region enriched"	"Detected in all"	4	"basal ganglia: 231.1"	"HPA001922, CAB003851"	Enhanced	Supported	Approved	Cytosol		NA	NA				"Cluster 7: Kidney - Transmembrane transport"	"Cluster 21: OE19 - Mitochondria"	"Cluster 27: Mucus-secreting cells - Mucin production"	Cytosol		"CAB003851: AB_562338, HPA001922: AB_1079743"	"unprognostic (1.17e-2)"	"unprognostic (4.33e-2)"	"unprognostic (7.84e-2)"	"unprognostic (2.45e-2)"	"unprognostic (4.52e-2)"	"unprognostic (1.21e-1)"	"prognostic unfavorable (5.85e-4)"	"unprognostic (8.33e-2)"	"unprognostic (1.52e-2)"	"unprognostic (2.35e-1)"	"unprognostic (3.43e-2)"	"unprognostic (1.35e-2)"	"prognostic favorable (1.12e-6)"	"unprognostic (1.11e-1)"	"unprognostic (9.85e-3)"	"unprognostic (4.86e-3)"	"unprognostic (3.64e-2)"	0.6	80.8	74.0	2.6	118.6	0.8	4.4	24.6	91.9	7.5	0.0	19.7	12.4	1.9	1.9	7.5	4.2	24.9	9.5	76.2	34.5	152.4	36.1	14.2	1.0	35.8	22.0	1.6	106.2	57.1	37.9	2.1	32.8	12.8	17.3	27.3	88.7	0.8	0.2	3.5	21.7	0.7	15.8	1.2	110.8	3.6	32.4	0.5	162.8	0.3	0.9	4.0	3.4	67.3	6.2	46.3	0.5	3.6	0.0	0.0	0.8	0.0	0.1	0.1	0.0	4.3	6.4	0.1	4.6	0.2	30.2	7.9	4.4	0.3	0.1	1.0	2.3	2.2	4.3	22.1	0.7	0.0	6.6	0.3	3.1	0.0	0.0	0.0	0.0	22.1	29.6	1.1	0.0	15.6	7.7	0.7	2.8	162.8	7.0	4.3	1.2	1.1	10.2	3.4	52.1	9.3	7.7	27.4	8.9	1.8	2.7	5.2	0.1	0.0	3.1	0.0	0.1	0.6	0.1	0.0	0.1	0.2	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	74.0	118.6	24.6	91.9	76.2	34.5	35.8	22.0	32.8	15.8	32.4	67.3	0.0	9.6	29.3	10.4	0.5	1.3	1.1	1.1	0.6	64.1	8.5	5.6	5.1	25.8	4.5	14.7	0.0	0.2	0.1	4.3	72.4	25.1	0.8	3.1	0.6	0.4	6.7	4.0	82.0	28.8	1.4	1.0	17.3	8.0	0.0	6.2	0.4	8.5	0.3	92.5	45.8	112.6	6.1	0.6	0.3	0.3	0.0	0.6	16.0	3.7	0.6	11.5	0.0	51.8	18.6	15.3	17.2	0.0	0.2	5.0	6.0	13.5	1.2	7.3	0.0	0.0	0.7	1.0	3.6	0.5	1.1	1.5	0.3	2.5	7.7	2.6
RAP1GAP2	"GARNL4, KIAA1039"	ENSG00000132359	"RAP1 GTPase activating protein 2"	Q684P5	17	2755705-3037741	"Predicted intracellular proteins"		"GTPase activation"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 27.7;pancreas: 37.3"	"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 132.8;Inhibitory neurons: 67.9"	"Low cancer specificity"	"Detected in all"			"Group enriched"	"Detected in many"	12	"amygdala: 10.6;basal ganglia: 13.6;cerebral cortex: 11.0;hippocampal formation: 17.9;white matter: 11.9"	"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"SH-SY5Y: 52.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA022148, HPA022896"	Approved		Supported	"Nuclear membrane,Cytosol"		NA	NA		21000	"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	"Nuclear membrane, Cytosol"		"HPA022148: AB_1849474, HPA022896: AB_1849476"	"unprognostic (1.85e-3)"	"unprognostic (1.02e-2)"	"unprognostic (8.92e-2)"	"unprognostic (5.39e-1)"	"unprognostic (4.04e-2)"	"unprognostic (3.92e-1)"	"unprognostic (6.52e-5)"	"unprognostic (1.18e-2)"	"unprognostic (2.91e-1)"	"unprognostic (2.22e-1)"	"unprognostic (1.66e-2)"	"unprognostic (9.64e-2)"	"prognostic favorable (1.36e-6)"	"unprognostic (3.44e-2)"	"unprognostic (6.38e-2)"	"unprognostic (9.33e-2)"	"unprognostic (7.50e-2)"	1.8	6.4	10.6	4.1	13.6	27.7	4.4	0.9	11.0	3.9	0.0	7.9	8.7	4.1	1.1	3.1	8.1	4.0	14.5	17.9	1.1	5.2	0.6	3.5	2.9	0.0	0.0	4.6	37.3	4.2	5.1	4.9	0.0	3.8	8.1	7.2	10.9	4.7	0.8	3.3	8.2	3.3	0.0	3.9	22.4	3.2	0.0	2.8	2.5	2.0	2.5	2.0	2.5	11.9	8.1	9.9	1.9	8.1	0.0	0.0	15.9	10.7	5.0	1.3	1.2	21.9	3.5	3.0	2.9	1.4	13.5	11.0	6.4	20.0	0.4	0.0	6.9	3.7	14.1	9.9	1.9	0.8	3.9	0.5	17.0	5.5	13.9	7.2	0.2	3.7	21.4	1.4	0.0	9.1	3.1	2.0	11.7	3.9	9.5	13.4	6.9	7.8	5.9	4.1	21.6	52.3	15.5	15.8	6.9	7.4	7.8	2.3	2.4	9.1	14.3	1.6	9.1	0.0	0.0	1.2	0.5	6.9	15.1	0.9	1.4	2.1	2.8	2.7	1.1	0.2	0.9	2.1	1.0	0.2	0.1	1.0	4.2	1.9	3.9	1.7	1.0	1.4	10.6	13.6	0.9	11.0	17.9	1.1	0.0	0.0	0.0	0.0	0.0	11.9	1.5	6.4	2.5	13.7	5.6	2.0	6.6	1.8	1.2	23.6	9.9	7.6	20.2	11.5	2.8	12.9	33.3	7.5	27.2	15.2	9.8	6.0	6.1	9.2	6.8	1.6	48.1	0.8	132.8	12.0	6.0	2.2	18.8	9.2	6.3	3.0	3.6	0.8	3.4	37.0	67.9	21.7	8.2	11.1	4.3	8.3	1.8	11.0	3.6	47.8	12.0	2.1	35.0	8.0	4.2	12.4	24.1	1.5	6.4	16.5	5.7	0.8	4.2	4.6	0.0	7.9	2.5	0.4	3.4	2.8	0.4	3.4	8.2	1.5	14.0	11.3
RP1	"DCDC4A, ORP1"	ENSG00000104237	"RP1 axonemal microtubule associated"	P56715	8	54509422-54871720	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"Cilium biogenesis/degradation, Sensory transduction, Vision"		"Disease variant, Retinitis pigmentosa"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	23	"retina: 236.4"	"Group enriched"	"Detected in some"	4	"Cone photoreceptor cells: 333.6;Rod photoreceptor cells: 1115.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"EFO-21: 1.6;HDLM-2: 5.2;hTERT-RPE1: 2.0;RPTEC TERT1: 10.2;U-2197: 2.3"	"Not detected"	"Not detected"			"Region enhanced"	"Detected in single"		"midbrain: 1.3"	HPA042257	Enhanced					NA	NA				"Cluster 79: Retina - Phototransduction"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 46: Photoreceptor cells - Phototransduction"			"HPA042257: AB_10797385"	"unprognostic (3.19e-3)"	"unprognostic (2.63e-3)"	"unprognostic (1.16e-1)"	"unprognostic (1.58e-2)"	"unprognostic (1.70e-1)"	"unprognostic (9.16e-3)"		"unprognostic (6.24e-2)"		"unprognostic (4.56e-2)"	"unprognostic (4.13e-5)"	"unprognostic (2.48e-1)"	"unprognostic (2.16e-5)"	"unprognostic (8.92e-2)"	"unprognostic (6.18e-2)"	"unprognostic (1.89e-2)"	"unprognostic (8.96e-2)"	0.1	0.0	0.1	0.0	0.0	0.0	0.6	0.1	0.2	0.4	0.0	0.0	0.0	0.1	0.0	0.0	10.1	0.0	0.0	0.1	0.0	0.7	0.1	3.5	0.0	0.4	0.3	0.1	0.0	0.0	0.0	0.3	0.1	0.0	0.0	236.4	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.3	0.5	1.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.5	0.0	1.6	0.0	0.1	0.0	0.7	0.0	0.0	5.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	2.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	10.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.3	0.1	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.2	0.1	0.0	0.4	0.3	0.1	0.0	0.1	0.1	0.5	16.0	4.8	0.0	0.0	0.0	0.0	1.2	0.0	72.5	3.0	1.4	0.4	0.0	31.1	5.5	333.6	0.0	0.0	0.0	3.9	0.0	0.3	81.9	0.4	10.3	0.0	0.0	0.0	0.0	0.0	0.4	0.0	1.9	0.0	0.0	0.0	0.0	0.0	32.0	0.2	0.0	2.0	0.0	0.0	0.0	0.0	0.5	1.8	0.0	0.0	130.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.2	149.0	1115.8	0.0	0.0	0.4	3.2	2.0	0.0	0.0	0.0	0.1	0.1	0.0	0.1
SERPINA4	"KAL, kallistatin, KLST, KST, PI4"	ENSG00000100665	"Serpin family A member 4"	P29622	14	94561442-94569913	"Plasma proteins, Predicted secreted proteins"		"Protease inhibitor, Serine protease inhibitor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	5	"liver: 550.0"	"Cell type enhanced"	"Detected in some"		"Cholangiocytes: 245.9;Exocrine glandular cells: 93.8;Hepatocytes: 478.5;Pancreatic endocrine cells: 62.1"	"Cancer enriched"	"Detected in many"	4	"liver cancer: 94.8"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	4	"Hep G2: 28.4"					"Not detected"	"Not detected"			"HPA003607, HPA068939"	Approved		Uncertain	Vesicles	"Secreted to blood"	NA	NA	14500000000	14000000000		"Cluster 85: Liver - Metabolism"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 2: Hepatocytes - Metabolism"	Vesicles		"HPA003607: AB_1079914, HPA068939: "	"unprognostic (1.65e-3)"		"unprognostic (4.13e-2)"	"prognostic favorable (2.95e-4)"			"unprognostic (2.09e-3)"	"unprognostic (1.99e-3)"		"unprognostic (2.82e-1)"	"unprognostic (4.03e-3)"	"unprognostic (1.02e-2)"	"unprognostic (2.24e-4)"	"unprognostic (1.08e-1)"	"unprognostic (5.45e-2)"			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.0	0.0	0.0	2.8	0.4	41.0	0.0	1.5	53.4	0.0	0.0	0.0	7.3	550.0	0.0	0.0	0.0	0.0	0.0	116.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	5.5	0.0	0.0	0.3	0.0	0.0	0.0	27.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	28.4	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	245.9	0.0	3.7	0.0	0.0	0.0	0.0	11.7	30.0	0.0	3.3	0.3	0.3	0.0	2.7	0.0	93.8	0.0	0.0	5.1	4.5	0.0	0.2	5.3	478.5	0.0	0.0	0.0	0.0	0.0	9.7	0.0	0.0	0.0	0.2	0.0	0.0	1.0	0.0	0.0	0.0	0.0	62.1	0.0	0.0	0.0	0.0	0.0	2.1	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0
SH3GL2	"CNSA2, EEN-B1, SH3D2A, SH3P4"	ENSG00000107295	"SH3 domain containing GRB2 like 2, endophilin A1"	Q99962	9	17579066-17797124	"Predicted intracellular proteins"	Endocytosis			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 123.8;retina: 75.0"	"Cell type enhanced"	"Detected in some"		"Bipolar cells: 89.4;Excitatory neurons: 390.8;Inhibitory neurons: 140.9"	"Cancer enhanced"	"Detected in many"		"glioma: 8.0"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HEK 293: 9.3;HeLa: 21.1;JURKAT: 18.7;RT4: 41.8;SCLC-21H: 26.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB010056, HPA026685, HPA063573"	Enhanced	Supported	Approved	"Microtubules,Cytokinetic bridge,Mitotic spindle"		Yes	No				"Cluster 6: Brain - Smell perception"	"Cluster 15: RT4 - Unknown function"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	Microtubules	"Cytokinetic bridge, Mitotic spindle"	"CAB010056: AB_628099, HPA026685: AB_1856817, HPA063573: AB_2685045"	"unprognostic (4.78e-2)"	"unprognostic (3.24e-2)"	"unprognostic (1.68e-2)"	"unprognostic (5.05e-5)"	"unprognostic (4.23e-2)"	"unprognostic (3.40e-1)"	"unprognostic (1.21e-1)"	"unprognostic (5.90e-2)"	"unprognostic (3.90e-1)"	"unprognostic (5.07e-3)"	"unprognostic (8.76e-3)"	"unprognostic (1.26e-1)"	"prognostic favorable (6.68e-12)"	"unprognostic (2.65e-2)"	"unprognostic (8.29e-2)"	"unprognostic (2.25e-2)"	"unprognostic (8.44e-2)"	0.3	0.2	63.0	0.1	69.0	0.0	0.1	92.3	123.8	2.3	1.9	0.5	0.2	2.2	1.2	0.5	2.0	0.0	4.3	77.7	26.6	16.8	0.2	1.1	0.0	27.9	28.5	1.8	3.0	0.3	26.2	0.0	25.9	1.8	0.6	75.0	0.1	0.1	0.1	0.1	0.5	1.7	29.3	0.1	8.7	6.5	41.1	0.7	1.5	0.0	0.0	4.3	0.4	55.5	0.0	0.0	0.9	0.0	0.0	0.0	0.0	2.0	7.5	0.8	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.6	0.0	0.0	0.0	9.3	0.0	21.1	0.0	0.1	0.0	1.0	0.0	0.0	0.1	0.0	0.0	0.0	18.7	0.0	0.1	0.0	0.0	0.1	0.2	2.5	0.0	2.4	0.0	0.0	0.0	0.0	41.8	26.5	0.0	0.3	0.0	0.8	0.8	0.0	0.0	0.0	0.0	2.2	0.0	1.5	0.0	0.4	0.0	1.3	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	63.0	69.0	92.3	123.8	77.7	26.6	27.9	28.5	25.9	29.3	41.1	55.5	0.0	0.0	0.0	16.3	0.0	0.1	0.4	0.0	0.0	89.4	0.1	0.0	1.8	0.0	0.0	7.3	22.9	0.0	0.0	0.1	11.7	0.0	16.7	0.2	0.1	0.3	5.3	0.0	390.8	0.0	0.0	0.1	0.0	0.1	0.0	0.3	0.0	0.0	0.1	13.5	140.9	0.7	0.0	0.0	0.3	47.4	1.2	0.1	0.0	13.1	0.1	9.0	0.0	41.7	10.2	0.2	0.1	0.4	0.0	2.2	0.0	22.2	0.0	28.0	0.0	0.0	0.1	2.4	6.1	0.0	0.0	0.1	0.0	1.2	0.7	0.4
SLC12A3	NCCT	ENSG00000070915	"Solute carrier family 12 member 3"	P55017	16	56865207-56915850	"Disease related genes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted membrane proteins, Transporters"	"Ion transport, Sodium transport, Symport, Transport"		"Disease variant, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	101	"kidney: 101.7"	"Cell type enhanced"	"Detected in some"		"Collecting duct cells: 3.7;dendritic cells: 4.2;Distal tubular cells: 5.9;Endometrial ciliated cells: 2.1;Glandular and luminal cells: 4.7;monocytes: 4.2"	"Cancer enhanced"	"Detected in some"		"renal cancer: 2.5"	"Low region specificity"	"Detected in single"			"Immune cell enriched"	"Detected in single"	20	"plasmacytoid DC: 14.9"	"Lineage enriched"	"Detected in single"	20	"dendritic cells: 14.9"	"Group enriched"	"Detected in some"	11	"BEWO: 7.0;HAP1: 4.0;HeLa: 8.9;SuSa: 2.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA028748	Enhanced					NA	NA			"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 7: Kidney - Transmembrane transport"	"Cluster 20: HeLa - Mitochondria"	"Cluster 65: Plasmacytoid DCs - Unknown function"			"HPA028748: AB_10603886"	"unprognostic (1.54e-3)"	"unprognostic (7.09e-5)"	"unprognostic (1.35e-1)"	"unprognostic (1.41e-2)"	"unprognostic (2.91e-1)"	"unprognostic (2.38e-4)"	"unprognostic (1.81e-1)"	"unprognostic (9.70e-2)"	"unprognostic (1.34e-1)"	"unprognostic (7.25e-2)"	"unprognostic (6.84e-2)"	"unprognostic (1.83e-1)"	"unprognostic (1.43e-1)"	"unprognostic (2.09e-1)"	"unprognostic (1.38e-1)"	"unprognostic (1.40e-2)"	"unprognostic (1.70e-1)"	0.0	0.0	0.3	0.4	0.8	0.0	0.1	0.0	1.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.6	0.0	101.7	0.0	0.1	0.8	0.2	0.2	0.0	0.2	0.0	0.0	0.2	0.3	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.5	0.1	0.0	0.2	0.4	0.0	0.0	0.7	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	7.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.5	4.0	0.0	0.0	0.0	0.0	0.0	8.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.3	0.0	2.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	14.9	0.0	0.1	0.3	0.8	0.0	1.0	0.6	0.0	0.2	0.2	0.3	0.0	0.2	0.2	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	3.7	0.0	0.0	4.2	0.0	5.9	0.0	0.4	2.1	0.4	0.1	0.0	0.0	1.0	0.0	0.0	0.0	0.0	4.7	0.0	0.0	0.0	0.0	0.1	0.0	1.2	0.0	0.0	0.0	0.0	0.3	0.0	0.9	0.0	0.0	4.2	0.0	0.0	1.0	0.6	0.0	0.0	0.0	0.2	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1
SLC1A1	"EAAC1, EAAT3"	ENSG00000106688	"Solute carrier family 1 member 1"	P43005	9	4490468-4587469	"Disease related genes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted membrane proteins, Transporters"	"Amino-acid transport, Symport, Transport"		"Disease variant, Schizophrenia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"epididymis: 45.0;intestine: 64.7;kidney: 51.0"	"Cell type enhanced"	"Detected in many"		"Alveolar cells type 1: 163.5;Glandular and luminal cells: 98.7;Hepatocytes: 68.4;Microglial cells: 67.5;Oligodendrocyte precursor cells: 161.4;Proximal enterocytes: 110.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"ASC TERT1: 29.1;HDLM-2: 70.9;HUVEC TERT2: 32.5;RPTEC TERT1: 66.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA062356	Enhanced					NA	NA			"Cluster 4: T-regs - Cell cycle regulation"	"Cluster 87: Intestine & Kidney - Transmembrane transport"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 44: Endometrium - Transcription"			"HPA062356: "	"unprognostic (1.28e-2)"	"unprognostic (2.37e-2)"	"unprognostic (6.83e-3)"	"unprognostic (3.07e-3)"	"unprognostic (2.04e-2)"	"unprognostic (1.51e-1)"	"unprognostic (1.07e-1)"	"unprognostic (4.28e-2)"	"unprognostic (1.58e-1)"	"unprognostic (2.71e-1)"	"unprognostic (1.35e-2)"	"unprognostic (1.25e-2)"	"prognostic favorable (2.86e-8)"	"unprognostic (2.68e-1)"	"unprognostic (9.49e-2)"	"unprognostic (7.78e-2)"	"unprognostic (2.64e-1)"	4.6	1.7	13.2	2.3	15.4	0.1	4.1	9.5	14.8	5.8	12.9	12.4	34.8	3.7	45.0	2.3	2.6	25.5	2.8	16.5	12.6	51.0	41.2	20.9	2.6	10.8	13.0	0.6	2.1	0.3	6.8	8.1	13.6	6.3	10.2	6.0	4.8	3.2	1.4	1.5	64.7	3.2	10.9	0.4	5.2	0.8	13.9	0.4	29.5	1.3	8.2	5.6	1.5	10.1	0.1	2.0	1.6	9.5	24.3	29.1	8.3	10.4	21.4	3.2	3.1	17.2	0.5	13.7	0.6	5.4	3.9	0.0	3.6	5.7	2.9	70.9	4.5	0.0	13.6	0.1	0.8	0.9	0.0	2.0	0.2	12.1	0.0	1.6	32.5	0.2	0.0	0.0	2.2	0.3	0.0	0.3	4.2	10.5	1.8	0.0	0.0	0.2	66.4	6.1	2.2	2.0	0.8	3.8	0.0	7.7	1.4	0.5	17.6	4.9	0.4	9.5	3.0	0.1	0.1	0.0	23.1	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	13.2	15.4	9.5	14.8	16.5	12.6	10.8	13.0	13.6	10.9	13.9	10.1	12.2	163.5	3.2	4.2	0.4	0.0	1.1	0.6	4.6	3.9	2.0	0.8	2.3	28.6	6.1	0.0	0.0	0.1	0.0	52.4	3.9	8.1	4.3	10.7	13.3	10.6	0.0	0.0	48.4	0.8	0.0	1.8	2.0	98.7	0.0	0.6	2.5	68.4	0.1	0.0	50.3	10.1	0.0	1.3	0.3	11.2	0.3	1.1	0.0	67.5	0.0	0.8	0.0	161.4	3.5	9.3	10.6	0.0	0.0	2.4	110.6	43.1	3.3	1.1	0.0	0.5	3.1	0.1	0.2	1.0	0.6	0.1	1.4	0.4	8.5	1.8
SLC4A2	"AE2, BND3L, EPB3L1, HKB3, NBND3"	ENSG00000164889	"Solute carrier family 4 member 2"	P04920	7	151057210-151076526	"Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Anion exchange, Antiport, Ion transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	6	"choroid plexus: 492.1"	"Cell type enhanced"	"Detected in many"		"Syncytiotrophoblasts: 91.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA019339	Enhanced		Uncertain	"Nuclear speckles,Plasma membrane,Cytosol"		NA	NA			"Cluster 29: Plasmacytoid DCs - Unknown function"	"Cluster 88: Choroid plexus - Transmembrane transport"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 40: Granulosa cells - Unknown function"	"Nuclear speckles, Plasma membrane"	Cytosol	"HPA019339: AB_1844825"	"unprognostic (1.19e-1)"	"unprognostic (3.33e-3)"	"unprognostic (8.12e-3)"	"unprognostic (1.10e-1)"	"unprognostic (1.20e-1)"	"unprognostic (1.49e-1)"	"prognostic unfavorable (9.04e-6)"	"unprognostic (1.24e-1)"	"unprognostic (4.23e-1)"	"unprognostic (3.30e-1)"	"unprognostic (1.07e-1)"	"unprognostic (3.21e-1)"	"prognostic favorable (1.26e-4)"	"unprognostic (4.67e-3)"	"unprognostic (1.22e-1)"	"unprognostic (1.28e-1)"	"unprognostic (2.36e-2)"	28.4	34.8	16.9	19.2	29.4	12.7	23.7	29.1	21.9	38.9	492.1	45.0	22.5	40.3	4.9	21.0	31.1	19.7	31.3	39.4	23.2	38.6	52.3	33.2	13.1	32.8	27.9	31.9	52.5	72.4	13.8	27.0	32.0	28.2	7.1	4.7	23.1	14.0	18.8	21.7	29.3	16.5	20.2	27.0	82.2	13.7	32.7	12.4	25.4	12.3	6.3	31.9	25.8	40.2	60.9	196.9	37.8	78.9	37.6	17.9	87.1	72.9	37.0	56.9	48.0	113.0	91.6	35.8	154.1	35.0	84.6	58.2	38.2	31.4	9.8	105.3	59.1	48.5	91.9	57.5	59.6	25.2	147.0	29.0	27.4	65.6	15.7	60.9	31.3	50.6	151.8	27.1	44.3	118.0	69.2	43.3	90.4	80.7	73.2	55.2	21.2	42.2	44.6	41.0	31.5	113.9	67.0	118.4	62.0	27.3	51.2	46.7	72.0	78.1	39.1	77.5	106.5	31.2	47.7	20.5	118.7	61.4	160.6	0.0	1.6	0.4	0.8	1.6	0.7	0.9	0.7	0.7	1.0	0.3	0.7	0.8	0.2	0.1	1.0	2.1	0.2	0.9	16.9	29.4	29.1	21.9	39.4	23.2	32.8	27.9	32.0	20.2	32.7	40.2	15.6	9.6	8.2	9.8	7.2	11.1	5.9	13.6	15.4	7.7	14.5	11.9	4.0	18.6	9.6	20.2	25.0	36.1	14.2	17.6	17.6	35.7	1.0	21.9	18.9	13.6	27.6	2.5	0.4	35.8	9.4	13.6	30.1	17.0	47.1	62.1	17.9	34.6	26.0	15.2	1.4	12.1	16.2	16.1	12.0	1.6	13.7	17.0	26.6	4.7	11.6	21.6	3.1	3.0	16.8	43.8	14.0	19.9	9.9	5.9	24.9	19.1	11.4	8.2	13.1	12.8	17.6	3.1	7.9	10.6	7.0	91.5	8.5	11.2	22.1	4.5
SLC9A3	NHE3	ENSG00000066230	"Solute carrier family 9 member A3"	P48764	5	470456-524449	"Disease related genes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Predicted membrane proteins, Transporters"	"Antiport, Ion transport, Sodium transport, Transport"		"Disease variant, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"gallbladder: 45.4;intestine: 94.3;kidney: 62.5;stomach 1: 50.1"	"Cell type enhanced"	"Detected in many"		"Alveolar cells type 1: 16.0;Collecting duct cells: 16.5;Proximal tubular cells: 40.7"	"Cancer enhanced"	"Detected in many"		"stomach cancer: 14.7"	"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in all"		"HDLM-2: 37.8"	"Region enriched"	"Detected in single"	14	"cerebellum: 4.1"	"Low region specificity"	"Detected in many"			"HPA036493, HPA036669"	Enhanced		Supported	"Plasma membrane"		NA	NA			"Cluster 32: T-cells - Unknown function"	"Cluster 87: Intestine & Kidney - Transmembrane transport"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	"Plasma membrane"		"HPA036493: AB_10673353, HPA036669: AB_10670843"	"unprognostic (1.27e-1)"	"unprognostic (4.88e-1)"	"unprognostic (9.35e-3)"	"unprognostic (1.11e-1)"	"unprognostic (2.37e-1)"	"unprognostic (3.35e-1)"	"unprognostic (2.51e-1)"	"unprognostic (9.40e-2)"	"prognostic unfavorable (8.49e-4)"	"unprognostic (5.18e-2)"	"unprognostic (1.29e-1)"	"unprognostic (3.69e-2)"	"unprognostic (3.84e-1)"	"unprognostic (1.30e-1)"	"unprognostic (1.04e-1)"	"unprognostic (1.24e-2)"	"unprognostic (1.32e-1)"	2.9	4.4	3.0	10.4	2.5	1.9	3.1	6.1	5.0	3.8	1.7	94.3	46.0	2.9	4.0	8.7	4.9	45.4	3.2	4.7	2.5	62.5	2.4	2.8	3.8	3.8	2.3	4.3	6.7	6.2	0.7	2.1	3.7	7.3	10.8	1.7	9.9	3.8	6.2	19.0	68.1	3.3	1.3	3.7	50.1	5.8	3.4	3.5	4.9	3.9	3.4	2.5	2.5	2.6	6.7	5.1	10.4	10.5	2.5	3.0	7.8	5.3	3.9	8.0	5.0	11.0	7.4	14.0	7.5	3.0	5.5	10.0	6.1	4.0	3.9	37.8	10.7	6.7	23.4	5.4	3.9	5.5	8.2	4.2	8.1	3.5	5.4	3.9	2.4	6.3	9.6	7.5	2.9	9.0	6.0	24.3	4.0	17.8	8.3	8.6	9.3	8.3	2.8	4.8	11.5	5.0	19.0	5.3	4.2	4.5	12.3	4.2	2.9	8.0	7.2	5.3	3.9	12.4	5.8	8.5	5.2	21.2	5.6	0.0	0.7	0.1	2.6	0.3	2.2	0.9	3.3	2.4	0.9	1.0	3.9	3.1	0.1	2.4	0.2	1.2	2.7	1.8	3.0	2.5	6.1	5.0	4.7	2.5	3.8	2.3	3.7	1.3	3.4	2.6	3.8	16.0	5.8	0.0	1.5	0.0	0.0	0.0	0.0	0.0	7.3	8.9	0.7	0.0	5.6	16.5	0.0	0.0	3.4	0.7	5.9	9.0	0.0	3.8	3.6	2.3	0.0	0.0	0.3	8.8	0.0	2.2	0.0	2.6	2.5	5.3	0.0	0.0	0.0	0.0	0.3	0.2	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	4.6	0.0	0.0	0.0	0.1	7.7	0.0	0.0	0.7	0.0	1.1	40.7	2.9	0.0	0.0	0.0	2.4	0.0	0.0	0.0	0.0	0.0	2.3	5.4	0.0	0.0
SMYD2	"HSKM-B, KMT3C, ZMYND14"	ENSG00000143499	"SET and MYND domain containing 2"	Q9NRG4	1	214281102-214337131	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Transcription, Transcription regulation"	"Chromatin regulator, Methyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in all"	5	"heart muscle: 198.8;skeletal muscle: 92.4"	"Cell type enhanced"	"Detected in many"		"Cardiomyocytes: 148.0;Cytotrophoblasts: 168.7;Early spermatids: 134.5;Extravillous trophoblasts: 110.5;Late spermatids: 120.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA029023	Uncertain		Approved	Mitochondria,Cytosol		NA	NA			"Cluster 15: NK-cells - Transcription"	"Cluster 38: Heart - Muscle contraction"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 47: Cytotrophoblasts - Unknown function"	Cytosol	Mitochondria	"HPA029023: AB_10601605"	"unprognostic (8.53e-2)"	"prognostic unfavorable (1.53e-5)"	"unprognostic (5.98e-2)"	"unprognostic (1.00e-2)"	"unprognostic (8.55e-2)"	"unprognostic (2.53e-2)"	"unprognostic (2.24e-2)"	"unprognostic (1.72e-2)"	"unprognostic (1.90e-3)"	"unprognostic (1.65e-1)"	"unprognostic (9.44e-2)"	"unprognostic (2.77e-1)"	"prognostic favorable (8.68e-4)"	"unprognostic (2.65e-1)"	"unprognostic (4.92e-2)"	"unprognostic (8.10e-2)"	"unprognostic (6.37e-2)"	15.5	15.0	12.4	9.0	13.0	8.9	18.7	13.5	32.1	12.2	17.8	12.9	13.8	9.5	7.5	18.1	27.6	9.3	198.8	14.6	16.1	20.4	26.2	18.1	13.5	14.7	16.7	12.0	19.1	6.9	17.1	27.3	14.2	12.1	14.3	14.3	13.7	8.1	92.4	11.4	12.6	10.1	14.5	15.1	19.2	24.3	14.4	22.6	20.3	4.2	14.2	11.8	10.1	14.4	64.4	14.5	22.7	16.8	21.7	37.7	102.4	36.6	28.8	41.8	46.6	68.3	52.0	34.6	36.7	39.8	19.7	28.9	21.3	63.5	36.8	28.3	29.8	10.1	30.0	46.7	19.9	47.6	7.4	42.9	31.2	30.5	21.6	27.2	32.1	29.5	35.0	7.5	36.4	33.5	32.6	26.1	21.3	32.4	26.3	20.6	59.9	27.8	33.9	45.2	23.7	55.3	28.9	95.0	73.3	47.8	75.5	30.1	38.6	32.9	49.6	18.0	55.2	33.2	13.0	39.2	43.1	35.1	37.8	15.8	10.0	14.4	15.0	5.7	17.8	15.4	22.5	19.9	9.5	7.5	19.3	18.0	0.9	29.2	1.9	6.4	26.7	13.0	12.4	13.0	13.5	32.1	14.6	16.1	14.7	16.7	14.2	14.5	14.4	14.4	10.5	19.2	9.7	7.5	13.7	20.6	16.5	40.0	25.0	8.7	16.8	19.9	148.0	24.3	17.7	3.7	0.0	168.7	12.2	10.0	31.3	34.3	134.5	48.7	9.9	15.6	4.2	8.6	60.7	20.0	110.5	11.1	11.7	17.4	3.8	27.9	17.2	20.3	38.4	15.2	26.9	13.4	14.2	21.5	10.6	120.4	11.8	11.4	16.0	22.5	11.7	28.1	9.2	7.1	10.3	26.1	11.7	3.8	16.4	16.1	21.9	34.6	69.6	8.0	13.1	6.8	16.7	13.9	39.6	28.9	18.0	85.9	16.8	30.0	19.3	10.9
TBC1D14	KIAA1322	ENSG00000132405	"TBC1 domain family member 14"	Q9P2M4	4	6909242-7033118	"Plasma proteins, Predicted intracellular proteins"	Autophagy	"GTPase activation"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Early spermatids: 68.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"HMC-1: 197.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036930, HPA067398"	Approved		Supported	"Nucleoplasm,Golgi apparatus,Vesicles"		Yes	No			"Cluster 9: Neutrophils - Innate immune response"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 29: Early spermatids - Spermatogenesis"	"Golgi apparatus, Vesicles"	Nucleoplasm	"HPA036930: AB_10670155, HPA067398: AB_2685833"	"unprognostic (3.05e-2)"	"unprognostic (7.48e-3)"	"unprognostic (4.80e-3)"	"unprognostic (8.13e-2)"	"unprognostic (2.83e-1)"	"unprognostic (1.78e-3)"	"unprognostic (9.63e-2)"	"unprognostic (5.25e-2)"	"unprognostic (9.71e-2)"	"unprognostic (7.65e-2)"	"unprognostic (1.80e-1)"	"unprognostic (2.90e-1)"	"prognostic favorable (5.28e-10)"	"unprognostic (1.56e-1)"	"unprognostic (3.50e-1)"	"unprognostic (5.13e-3)"	"unprognostic (4.12e-2)"	26.3	42.1	42.7	31.5	41.9	15.9	27.6	38.7	43.9	19.4	50.2	26.4	22.8	20.9	22.9	34.0	23.5	17.0	30.4	42.9	44.9	44.5	27.4	24.4	29.8	49.3	45.6	28.7	19.5	41.9	27.1	23.8	44.8	24.5	26.3	18.5	31.7	20.2	51.6	49.5	26.0	22.9	45.7	34.9	58.5	30.0	48.7	40.1	19.2	41.3	26.9	19.8	22.2	44.2	34.5	36.8	40.4	45.5	32.8	27.4	24.5	27.0	29.3	24.7	21.1	38.3	69.8	54.9	15.6	32.5	62.8	24.5	68.4	61.7	30.0	15.5	22.2	91.8	23.8	40.4	22.7	42.0	197.9	21.3	85.8	23.4	38.3	31.5	23.5	51.2	88.6	19.3	30.2	22.3	64.9	42.5	54.9	41.1	40.8	80.2	53.2	59.9	36.8	23.9	61.6	44.0	22.4	24.1	84.3	31.2	33.3	39.4	23.7	27.2	20.5	24.0	40.3	36.7	91.6	55.7	25.4	53.2	26.6	2.6	13.2	5.6	8.6	8.2	13.1	8.1	9.3	9.3	10.7	8.3	6.9	6.6	40.6	8.6	3.9	11.5	11.9	10.8	42.7	41.9	38.7	43.9	42.9	44.9	49.3	45.6	44.8	45.7	48.7	44.2	8.4	6.4	17.7	22.5	15.5	9.1	7.0	15.8	15.9	10.2	21.1	16.3	4.6	10.0	14.8	14.7	14.6	12.5	16.3	17.7	19.6	11.5	68.0	12.3	10.3	7.8	6.6	7.2	25.6	10.2	7.1	9.5	14.8	11.9	7.6	18.9	8.2	24.4	26.0	25.2	25.1	15.7	10.2	33.6	8.7	41.0	7.2	27.8	19.6	27.2	24.4	13.4	16.5	51.8	27.0	11.8	14.2	8.6	15.4	12.9	12.8	19.8	10.7	6.6	0.0	12.7	7.1	17.7	18.0	19.8	11.9	16.4	16.3	12.5	19.9	10.1
TBC1D9	"GRAMD9, KIAA0882, MDR1"	ENSG00000109436	"TBC1 domain family member 9"	Q6ZT07	4	140620782-140756385	"Predicted intracellular proteins"		"GTPase activation"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Breast glandular cells: 91.6"	"Cancer enriched"	"Detected in all"	7	"breast cancer: 85.0"	"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"memory B-cell: 5.9"	"Group enriched"	"Detected in many"	37	"B-cells: 5.9;dendritic cells: 3.2;monocytes: 1.7"	"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA000262, HPA006503"	Uncertain		Approved	Cytosol		NA	NA			"Cluster 19: B-cells - Humoral immune response"	"Cluster 19: Lung - Lung function"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 35: Glandular cells - Unknown function"	Cytosol		"HPA000262: AB_2665956, HPA006503: AB_2667604"	"unprognostic (1.41e-1)"	"unprognostic (1.35e-2)"	"unprognostic (2.41e-1)"	"unprognostic (6.49e-2)"	"unprognostic (3.00e-1)"	"unprognostic (1.22e-2)"	"unprognostic (9.17e-2)"	"unprognostic (2.11e-3)"	"unprognostic (2.64e-1)"	"unprognostic (2.66e-1)"	"unprognostic (2.96e-3)"	"unprognostic (6.77e-2)"	"prognostic favorable (1.61e-6)"	"unprognostic (2.17e-2)"	"unprognostic (1.11e-1)"	"unprognostic (6.72e-2)"	"unprognostic (2.16e-2)"	18.2	9.2	7.2	15.2	7.9	2.0	48.7	22.5	9.4	12.9	35.2	7.3	8.2	8.3	7.8	9.1	10.0	13.8	8.5	8.4	15.3	15.7	12.6	16.3	15.1	7.9	9.6	15.9	9.1	9.8	6.3	20.5	15.4	14.6	6.6	21.0	8.8	21.3	2.2	3.2	12.8	7.7	6.4	33.7	16.8	3.3	12.9	5.6	5.8	6.9	19.4	15.8	7.1	3.3	0.9	11.9	10.9	9.4	26.0	24.3	22.3	15.3	16.3	10.8	13.7	2.4	10.4	0.1	9.5	19.9	13.4	2.4	13.7	10.8	10.1	0.0	7.7	7.0	8.5	10.4	9.4	0.9	1.1	20.1	17.7	9.4	37.2	31.2	30.3	3.7	0.0	0.0	10.2	12.0	1.6	0.1	1.7	12.7	10.4	7.7	17.9	18.1	12.3	22.0	16.0	11.4	15.8	27.4	10.5	18.4	6.4	0.4	47.7	28.3	8.5	18.6	13.3	0.0	0.0	0.1	17.2	1.3	15.7	0.0	1.7	0.0	0.0	1.3	0.0	5.9	0.0	0.0	2.9	2.9	0.0	0.0	0.0	0.0	0.5	3.2	0.0	0.7	7.2	7.9	22.5	9.4	8.4	15.3	7.9	9.6	15.4	6.4	12.9	3.3	49.4	54.5	9.3	4.6	42.1	4.6	10.6	21.4	4.0	35.4	91.6	39.4	8.1	17.2	15.1	55.2	4.2	14.1	14.0	8.3	7.9	13.6	0.5	49.4	20.9	32.6	7.7	0.4	54.8	17.2	4.7	15.1	8.2	61.4	0.0	8.0	17.2	23.9	18.3	10.1	66.2	6.6	24.4	39.3	30.3	1.3	13.1	44.8	8.8	78.7	39.5	43.5	1.0	27.6	2.6	12.2	5.8	26.7	25.0	16.3	6.1	5.7	15.9	7.6	0.0	2.8	11.1	0.8	1.7	10.4	3.8	43.2	3.7	16.0	3.1	16.0
TFR2	"HFE3, TFRC2"	ENSG00000106327	"Transferrin receptor 2"	Q9UP52	7	100620416-100642779	"Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Plasma proteins, Predicted membrane proteins, Transporters"		Receptor	"Disease variant, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	15	"liver: 346.1"	"Group enriched"	"Detected in some"	13	"Erythroid cells: 152.8;Hepatocytes: 455.7"	"Cancer enriched"	"Detected in many"	70	"liver cancer: 136.2"	"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	22	"basophil: 2.5;eosinophil: 1.9"	"Lineage enriched"	"Detected in single"	25	"granulocytes: 2.5"	"Group enriched"	"Detected in some"	11	"HEL: 69.7;HMC-1: 92.7;K-562: 65.8"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"CAB016255, HPA017171, HPA073125"	Enhanced		Approved	"Golgi apparatus"		NA	NA		410000	"Cluster 46: Basophils - DNA binding"	"Cluster 60: Liver - Hemostasis & Lipid metabolism"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 15: Hepatocytes - Hemostasis"	"Golgi apparatus"		"CAB016255: AB_628395, HPA017171: , HPA073125: "	"unprognostic (4.18e-2)"	"unprognostic (1.97e-2)"	"unprognostic (2.74e-1)"	"unprognostic (1.04e-1)"	"unprognostic (1.26e-2)"	"unprognostic (4.13e-2)"	"prognostic favorable (2.48e-4)"	"unprognostic (2.29e-2)"	"unprognostic (4.49e-2)"	"unprognostic (9.26e-2)"	"unprognostic (1.93e-1)"	"unprognostic (2.90e-1)"	"unprognostic (1.18e-9)"	"unprognostic (6.51e-2)"	"unprognostic (1.68e-1)"	"unprognostic (3.28e-1)"	"unprognostic (8.18e-2)"	0.0	0.1	0.0	0.0	0.0	22.5	0.0	0.6	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.1	0.0	0.0	346.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.3	0.2	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	6.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	69.7	0.0	7.2	0.0	1.6	92.7	0.0	0.0	0.0	0.0	0.0	0.0	0.1	65.8	0.0	0.0	0.0	0.0	0.1	0.1	0.4	0.8	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	2.5	0.0	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.0	0.0	0.3	2.1	0.3	0.9	0.4	0.0	8.5	0.3	0.6	1.2	10.0	0.8	0.0	8.4	0.1	1.7	0.1	0.0	0.4	5.8	0.1	0.6	1.2	0.0	152.8	5.4	0.2	1.1	0.5	1.5	0.2	0.0	0.2	7.1	455.7	0.3	21.9	5.4	0.3	0.0	8.6	1.7	8.4	0.0	0.4	0.0	1.0	0.2	0.4	6.2	1.5	0.7	0.1	0.1	0.0	0.4	0.6	0.1	0.1	0.3	1.9	0.0	0.4	0.7	0.7	2.9	0.2	0.6	0.1	2.6	0.1	0.6	0.5
TM7SF2	"ANG1, DHCR14A, NET47"	ENSG00000149809	"Transmembrane 7 superfamily member 2"	O76062	11	65111845-65116384	"Enzymes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Cholesterol biosynthesis, Cholesterol metabolism, Lipid biosynthesis, Lipid metabolism, Steroid biosynthesis, Steroid metabolism, Sterol biosynthesis, Sterol metabolism"	Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"adrenal gland: 246.0"	"Cell type enhanced"	"Detected in all"		"Granulosa cells: 482.7;Hepatocytes: 220.6;Muller glia cells: 204.7;Theca cells: 204.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"plasmacytoid DC: 38.1"	"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"MCF7: 69.2;RPTEC TERT1: 86.2;T-47d: 143.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA030691, HPA072704"	Enhanced		Supported	"Endoplasmic reticulum,Vesicles"		NA	NA			"Cluster 15: NK-cells - Transcription"	"Cluster 35: Non-specific - Unknown function"	"Cluster 6: T47d - Mammary gland"	"Cluster 40: Granulosa cells - Unknown function"	"Endoplasmic reticulum"	Vesicles	"HPA030691: AB_10602480, HPA072704: AB_2686551"	"unprognostic (1.62e-1)"	"unprognostic (5.23e-2)"	"unprognostic (1.70e-2)"	"unprognostic (1.78e-1)"	"unprognostic (5.74e-2)"	"unprognostic (1.10e-1)"	"unprognostic (5.98e-2)"	"unprognostic (6.06e-2)"	"unprognostic (5.72e-2)"	"unprognostic (1.74e-2)"	"unprognostic (7.06e-2)"	"unprognostic (1.69e-1)"	"prognostic favorable (8.49e-8)"	"unprognostic (8.77e-2)"	"unprognostic (1.90e-1)"	"unprognostic (1.35e-1)"	"unprognostic (3.44e-2)"	63.4	246.0	27.8	2.6	28.5	4.1	29.1	32.8	33.9	17.4	64.1	7.8	9.4	3.4	17.0	39.6	12.8	7.0	47.3	30.0	29.7	18.9	86.4	10.1	3.4	34.0	32.0	36.5	69.9	36.3	19.5	3.9	32.5	41.1	3.9	6.0	46.9	6.0	7.1	68.2	8.3	1.9	30.1	5.1	35.6	11.5	32.6	5.6	15.5	3.7	8.4	5.5	22.1	35.1	7.7	10.9	27.3	35.1	8.1	1.3	15.4	1.8	4.5	2.7	3.0	26.0	35.8	16.3	26.9	2.2	1.0	13.3	11.6	21.2	1.9	16.7	5.0	10.2	2.7	54.5	18.8	4.2	10.6	3.7	5.0	14.6	3.9	12.6	3.9	28.7	5.8	13.9	0.8	69.2	8.3	18.6	12.6	18.4	11.2	22.4	1.2	39.9	86.2	12.6	27.2	30.5	1.2	28.2	6.1	19.5	143.9	11.4	3.1	0.4	3.4	3.8	2.3	27.1	18.1	8.4	2.5	5.9	1.0	1.1	1.6	3.4	9.1	1.5	7.0	12.4	5.6	7.8	1.5	11.9	11.8	9.0	1.1	12.5	0.9	38.1	5.6	4.9	27.8	28.5	32.8	33.9	30.0	29.7	34.0	32.0	32.5	30.1	32.6	35.1	4.0	9.6	43.7	23.5	12.7	1.9	6.2	33.6	5.7	19.2	52.2	38.5	99.4	52.9	36.6	44.1	10.4	72.9	16.3	23.3	17.6	27.1	28.8	17.9	2.6	5.7	59.4	13.7	11.6	27.7	4.6	4.3	31.1	16.5	7.0	482.7	5.0	220.6	15.6	25.2	15.3	21.8	52.9	6.3	2.7	59.3	9.9	5.8	12.4	2.8	9.4	204.7	7.2	17.1	36.5	21.7	23.7	2.2	12.9	31.3	29.0	77.5	37.9	23.6	13.1	1.6	21.8	13.3	17.9	18.0	7.0	82.1	8.3	204.8	19.0	10.4
TMEM116	FLJ90167	ENSG00000198270	"Transmembrane protein 116"	Q8NCL8	12	111931282-112013185	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Tissue enhanced"	"Detected in all"		"parathyroid gland: 59.7"	"Cell type enhanced"	"Detected in many"		"Early spermatids: 67.8;Spermatocytes: 123.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Lineage enriched"	"Detected in all"	4	"T-cells: 19.3"	"Cell line enhanced"	"Detected in many"		"RT4: 33.1"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA040720	Approved		Approved	Nucleoplasm,Microtubules		NA	NA			"Cluster 4: T-regs - Cell cycle regulation"	"Cluster 48: Parathyroid gland - membrane proteins"	"Cluster 15: RT4 - Unknown function"	"Cluster 13: Spermatocytes & Spermatogonia - Spermatogenesis"	Microtubules	Nucleoplasm	"HPA040720: AB_10795623"	"unprognostic (8.91e-2)"	"unprognostic (1.95e-3)"	"unprognostic (1.18e-2)"	"unprognostic (1.71e-1)"	"unprognostic (5.48e-2)"	"unprognostic (3.25e-1)"	"unprognostic (2.93e-2)"	"unprognostic (6.03e-2)"	"unprognostic (2.00e-2)"	"unprognostic (1.34e-1)"	"unprognostic (3.27e-3)"	"unprognostic (9.12e-2)"	"prognostic favorable (1.08e-4)"	"unprognostic (2.41e-1)"	"unprognostic (1.33e-1)"	"unprognostic (2.85e-2)"	"unprognostic (3.19e-3)"	3.8	8.8	7.0	2.2	7.8	1.2	11.4	9.2	8.4	6.0	27.5	4.2	11.1	2.7	7.1	4.2	4.9	6.8	26.3	6.4	6.5	30.8	12.3	8.5	4.5	7.2	7.5	5.2	4.2	59.7	6.5	2.9	7.2	3.9	3.7	7.0	13.3	5.9	6.6	11.1	6.3	2.1	6.9	3.4	10.2	27.1	7.5	5.4	6.3	5.8	6.8	7.4	3.2	8.5	6.2	6.4	8.9	9.7	8.3	6.6	6.0	5.1	7.5	6.1	6.6	4.6	5.1	6.9	2.9	3.5	7.6	5.9	4.8	5.1	5.4	17.1	4.1	4.4	5.4	5.1	13.2	1.6	0.7	7.8	8.5	7.7	13.5	6.7	2.2	13.2	8.7	5.0	6.5	9.4	2.3	14.2	10.6	14.5	3.9	7.0	3.8	12.2	18.9	33.1	8.1	5.6	5.3	4.4	8.3	11.7	16.0	22.9	1.6	5.8	1.8	5.1	2.2	6.5	12.1	6.6	7.9	5.5	8.0	1.1	2.6	4.5	8.1	4.5	6.8	2.9	18.5	15.6	2.9	3.6	9.6	10.8	0.4	2.4	3.5	4.2	19.3	4.0	7.0	7.8	9.2	8.4	6.4	6.5	7.2	7.5	7.2	6.9	7.5	8.5	4.0	3.2	18.5	17.3	6.2	5.5	6.2	8.8	7.4	11.2	14.0	12.8	21.7	7.2	10.1	29.5	16.7	18.6	10.2	5.7	23.5	4.2	67.8	7.0	4.3	3.5	0.0	3.4	28.3	4.0	5.9	5.9	7.7	3.7	5.7	7.0	2.2	5.4	5.1	10.1	25.6	4.6	24.4	4.1	4.5	33.5	9.3	3.9	7.2	7.5	3.6	13.4	11.3	13.0	33.3	2.7	3.2	4.9	5.5	4.2	20.9	10.3	18.6	17.3	6.6	6.5	6.6	123.5	37.4	6.2	5.4	40.1	17.4	7.0	6.0	7.6
TMEM161B	MGC33214	ENSG00000164180	"Transmembrane protein 161B"	Q8NDZ6	5	88189633-88269476	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Oligodendrocyte precursor cells: 59.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"HEL: 82.1;HMC-1: 85.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA044562	Uncertain					NA	NA			"Cluster 49: Eosinophils - Unknown function"	"Cluster 87: Intestine & Kidney - Transmembrane transport"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 52: Non-specific - Transcription"			"HPA044562: AB_10794291"	"unprognostic (2.08e-1)"	"unprognostic (6.02e-2)"	"unprognostic (2.06e-2)"	"unprognostic (5.64e-2)"	"unprognostic (2.27e-1)"	"unprognostic (1.05e-1)"	"unprognostic (3.07e-2)"	"unprognostic (1.12e-1)"	"unprognostic (7.38e-2)"	"unprognostic (1.18e-3)"	"unprognostic (1.58e-1)"	"unprognostic (1.01e-1)"	"unprognostic (6.96e-3)"	"unprognostic (1.55e-2)"	"unprognostic (3.04e-1)"	"unprognostic (7.62e-3)"	"unprognostic (9.35e-2)"	4.6	5.8	5.0	5.8	4.7	6.2	16.0	7.3	6.3	6.5	3.0	9.7	12.4	6.4	14.2	7.8	7.1	5.6	4.8	4.3	3.8	9.7	11.9	10.1	9.1	3.1	3.1	11.2	14.0	23.0	4.8	8.1	3.2	12.3	11.3	18.2	14.1	8.9	6.4	15.6	11.5	5.8	3.0	6.4	22.9	12.5	4.0	8.6	20.9	7.0	9.5	7.4	6.0	5.6	11.8	8.0	8.7	9.5	5.4	10.3	18.6	10.3	15.4	14.6	21.2	8.9	30.2	18.2	5.2	7.7	26.6	12.3	10.2	13.3	18.4	16.4	10.7	82.1	10.3	5.9	14.0	15.9	85.2	9.2	19.1	12.4	18.3	10.4	6.5	11.9	40.5	16.0	12.7	5.5	11.6	13.9	5.6	8.7	14.3	9.7	10.1	19.9	13.0	16.4	11.1	9.3	5.9	16.3	24.5	7.7	9.8	14.5	5.4	9.5	8.7	13.7	18.9	19.6	33.3	14.9	23.3	15.7	13.4	1.5	1.4	1.0	2.9	2.8	2.9	2.2	2.4	2.1	0.8	2.1	2.4	1.9	0.8	2.9	1.1	2.6	2.1	1.2	5.0	4.7	7.3	6.3	4.3	3.8	3.1	3.1	3.2	3.0	4.0	5.6	9.8	28.9	16.4	37.2	19.2	7.8	8.0	12.0	5.7	15.8	13.6	9.7	16.3	11.5	15.0	9.2	16.7	9.3	17.9	14.7	3.9	8.8	3.6	10.2	11.4	7.7	14.3	10.3	43.4	9.7	4.1	9.8	12.2	14.0	16.5	14.4	15.0	23.1	5.3	6.7	46.3	13.7	6.1	11.8	5.5	3.1	10.5	8.2	0.0	28.1	7.1	15.6	22.6	59.3	55.0	11.3	6.6	12.8	13.1	9.4	11.3	6.4	9.4	22.2	6.6	8.9	8.9	35.8	12.6	9.3	7.1	15.1	15.8	11.3	14.3	7.5
TMEM171	PRP2	ENSG00000157111	"Transmembrane protein 171"	Q8WVE6	5	73120569-73131809	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"intestine: 35.6;kidney: 10.8;lymphoid tissue: 14.3;stomach 1: 25.4;thyroid gland: 31.1"	"Cell type enhanced"	"Detected in many"		"Cholangiocytes: 28.6;Distal enterocytes: 106.0;Gastric mucus-secreting cells: 29.6;Ionocytes: 40.7;Paneth cells: 63.4;Proximal enterocytes: 41.9;Undifferentiated cells: 51.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	10	"MAIT T-cell: 24.1;memory CD8 T-cell: 8.2"	"Lineage enriched"	"Detected in single"	89	"T-cells: 24.1"	"Cell line enhanced"	"Detected in many"		"BJ hTERT+: 35.0;LHCN-M2: 66.1;RPTEC TERT1: 51.5;WM-115: 177.2"	"Not detected"	"Not detected"			"Region enhanced"	"Detected in some"		"spinal cord: 3.7"	HPA042308	Approved					NA	NA			"Cluster 16: MAIT-cells - Unknown function"	"Cluster 9: Intestine - Unknown function"	"Cluster 17: WM-115 - Nervous system development"	"Cluster 53: Intestinal epithelial cells - Unknown function"			"HPA042308: AB_10796901"	"unprognostic (7.34e-2)"	"unprognostic (4.13e-2)"	"unprognostic (1.67e-1)"	"unprognostic (7.74e-3)"	"unprognostic (2.81e-5)"	"unprognostic (1.12e-1)"	"unprognostic (1.40e-1)"	"unprognostic (1.44e-3)"	"unprognostic (1.77e-1)"	"unprognostic (1.85e-1)"	"unprognostic (4.20e-2)"	"unprognostic (1.22e-1)"	"prognostic favorable (3.93e-10)"	"unprognostic (6.13e-3)"	"unprognostic (2.43e-1)"	"unprognostic (9.10e-3)"	"unprognostic (1.57e-1)"	0.1	0.1	2.0	3.1	3.5	0.0	1.6	1.8	2.8	0.3	1.3	35.6	27.7	0.0	0.7	4.8	0.4	0.8	0.0	2.1	2.5	10.8	2.1	0.2	0.4	1.9	2.9	0.1	0.8	0.9	0.1	0.5	2.2	0.1	33.1	0.1	0.5	3.8	0.7	1.0	19.8	1.2	1.5	14.3	25.4	0.6	2.9	0.5	31.1	0.6	3.0	0.7	0.2	3.7	23.4	1.0	0.0	0.2	7.3	10.3	0.0	7.1	35.0	13.6	23.1	0.7	10.7	0.0	15.0	9.4	2.7	17.3	0.3	1.1	11.2	0.0	3.7	0.0	0.2	0.0	2.7	0.0	1.1	2.2	0.9	18.9	1.6	5.3	8.7	0.0	0.0	0.3	66.1	2.3	0.0	0.1	1.9	0.3	1.4	0.0	0.0	12.5	51.5	0.3	0.1	0.0	5.4	0.2	0.1	3.9	1.2	0.1	0.0	0.2	1.2	19.8	0.4	0.0	0.0	0.0	18.1	0.0	177.2	0.0	0.0	0.0	1.6	0.0	24.1	0.0	0.9	8.2	0.0	0.0	0.0	0.9	0.2	0.0	0.0	0.0	0.0	0.8	2.0	3.5	1.8	2.8	2.1	2.5	1.9	2.9	2.2	1.5	2.9	3.7	0.2	0.0	0.0	0.0	0.6	1.8	0.6	25.4	1.2	0.0	6.8	0.4	0.3	28.6	9.2	7.3	0.0	0.2	0.0	106.0	15.6	6.9	0.0	0.2	0.1	0.9	2.4	0.0	0.3	9.9	0.4	1.4	29.6	0.5	0.0	0.0	0.7	1.5	1.3	0.0	0.3	21.2	40.7	0.0	0.4	0.0	0.0	0.1	1.8	1.9	0.0	0.0	5.2	1.0	9.7	10.4	63.4	0.0	0.1	0.8	41.9	8.9	4.4	0.0	0.0	0.0	0.4	0.2	1.7	6.5	1.7	0.5	1.0	0.0	51.4	1.0
TMEM86B	MGC30208	ENSG00000180089	"Transmembrane protein 86B"	Q8N661	19	55226638-55228784	"Enzymes, Predicted membrane proteins"		Hydrolase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"gallbladder: 11.0;liver: 16.9"	"Cell type enhanced"	"Detected in many"		"Cholangiocytes: 37.1;Erythroid cells: 66.5;Hepatocytes: 33.3"	"Cancer enriched"	"Detected in all"	5	"liver cancer: 10.0"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"Hep G2: 7.6;RPMI-8226: 8.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in some"			HPA057689	Uncertain		Uncertain	Midbody,Centrosome		Yes	No			"Cluster 32: T-cells - Unknown function"	"Cluster 45: Intestine - Brush border"	"Cluster 39: CACO-2 - Unknown function"	"Cluster 6: Erythroid cells - Oxygen transport"	Centrosome	Midbody	"HPA057689: AB_2683504"	"unprognostic (2.36e-1)"	"unprognostic (1.10e-1)"	"unprognostic (2.76e-5)"	"unprognostic (1.87e-1)"	"unprognostic (1.29e-1)"	"unprognostic (6.55e-2)"	"prognostic favorable (3.13e-4)"	"unprognostic (1.10e-2)"	"unprognostic (2.00e-1)"	"unprognostic (2.10e-1)"	"prognostic favorable (9.97e-6)"	"unprognostic (1.96e-2)"	"unprognostic (6.63e-8)"	"unprognostic (2.28e-1)"	"unprognostic (1.07e-1)"	"unprognostic (3.70e-1)"	"unprognostic (3.19e-3)"	0.9	2.1	4.6	2.4	5.1	6.9	0.9	4.7	6.8	1.4	3.8	1.8	9.7	1.5	0.1	1.0	1.8	11.0	0.8	4.6	3.9	1.3	16.9	1.2	1.7	4.4	3.7	1.2	0.6	0.5	2.9	0.6	4.3	1.8	0.3	0.7	0.9	0.6	1.5	1.6	10.2	0.3	3.4	3.6	4.1	3.0	4.2	1.6	2.3	0.4	1.2	1.2	1.0	4.2	1.7	0.0	0.9	1.1	0.1	0.0	3.0	1.2	0.3	0.9	0.9	5.4	1.4	2.4	0.4	0.4	0.3	0.7	0.1	0.2	0.0	0.3	4.0	1.9	0.4	7.6	0.9	1.6	0.9	0.7	1.5	0.5	0.0	0.4	0.0	3.8	3.8	1.4	0.4	1.0	3.8	5.3	0.2	0.6	1.7	3.8	0.5	8.1	0.8	1.6	0.7	1.7	0.0	0.9	4.4	0.7	1.0	1.9	1.2	1.9	1.1	1.1	0.9	1.4	1.5	4.1	1.0	5.2	0.4	0.0	0.3	0.2	0.4	0.0	0.0	0.0	0.2	0.1	0.0	0.1	0.2	0.5	0.3	0.2	0.0	0.6	0.0	0.2	4.6	5.1	4.7	6.8	4.6	3.9	4.4	3.7	4.3	3.4	4.2	4.2	1.5	6.4	2.7	4.9	1.3	3.3	0.4	1.0	1.8	6.0	1.9	1.1	0.6	37.1	1.5	0.0	2.1	0.4	1.9	2.0	0.0	1.1	3.0	2.5	1.0	1.9	10.7	66.5	5.2	0.2	0.3	0.9	12.8	1.8	0.0	2.5	1.4	33.3	1.0	10.1	4.5	2.8	4.1	5.9	2.8	4.5	0.9	2.5	3.6	0.0	3.1	1.2	2.1	2.5	3.3	1.1	0.3	0.4	2.9	1.2	14.5	1.0	3.8	3.9	0.0	0.8	1.3	1.8	1.2	0.8	2.3	0.3	3.3	1.9	2.7	2.4
TRIM50	"FLJ32804, TRIM50A"	ENSG00000146755	"Tripartite motif containing 50"	Q86XT4	7	73312536-73328082	"Enzymes, Human disease related genes, Predicted intracellular proteins"	"Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	4	"pancreas: 29.1;parathyroid gland: 33.3;stomach 1: 48.7"	"Cell type enhanced"	"Detected in some"		"Early spermatids: 2.3;Gastric mucus-secreting cells: 17.9;Spermatocytes: 5.2;Spermatogonia: 4.2"	"Group enriched"	"Detected in some"	8	"liver cancer: 2.9;renal cancer: 6.0"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	32	"Hep G2: 6.8"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			"HPA019862, HPA047843"	Uncertain		Approved	Cytosol		NA	NA				"Cluster 29: Non-specific - Vesicular transport"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 20: Spermatogonia & Spermatocytes - Spermatogenesis"	Cytosol		"HPA019862: AB_1858305, HPA047843: AB_2680176"	"unprognostic (1.93e-1)"	"unprognostic (3.93e-1)"	"unprognostic (1.07e-2)"	"unprognostic (5.96e-2)"	"unprognostic (3.87e-1)"	"unprognostic (2.66e-2)"	"unprognostic (1.49e-1)"	"unprognostic (3.04e-3)"	"unprognostic (2.63e-2)"	"unprognostic (2.00e-1)"	"unprognostic (2.13e-1)"	"unprognostic (1.33e-1)"	"prognostic favorable (9.36e-7)"	"unprognostic (3.91e-2)"	"unprognostic (1.60e-1)"	"unprognostic (1.20e-1)"	"unprognostic (2.25e-1)"	0.5	0.2	0.1	0.0	0.0	0.0	0.2	0.0	0.2	0.0	0.1	0.2	1.1	0.0	0.0	0.1	0.1	0.1	0.1	0.1	0.1	6.8	0.3	0.1	0.0	0.1	0.1	0.2	29.1	33.3	0.0	0.3	0.1	0.0	0.0	0.0	0.1	0.0	1.7	0.0	0.9	0.0	0.1	0.4	48.7	8.7	0.1	0.0	0.3	0.4	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	6.8	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	1.1	2.3	0.0	0.0	0.0	0.0	0.0	0.1	0.9	0.1	0.0	17.9	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.1	0.0	0.0	0.0	0.0	0.9	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.5	0.1	0.8	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	5.2	4.2	0.0	0.0	0.1	0.0	0.0	0.1	0.0
TRIM73	TRIM50B	ENSG00000178809	"Tripartite motif containing 73"	Q86UV7	7	75395063-75410996	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"stomach 1: 21.6"	"Cell type enhanced"	"Detected in many"		"Granulosa cells: 41.9;Horizontal cells: 32.0"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"HEK 293: 6.0;Hep G2: 10.5"									"HPA047843, HPA051845"	Uncertain		Uncertain	Cytosol		NA	NA			"Cluster 15: NK-cells - Transcription"	"Cluster 71: Testis - DNA repair"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 40: Granulosa cells - Unknown function"	Cytosol		"HPA047843: AB_2680176, HPA051845: AB_2681635"	"unprognostic (1.01e-2)"	"unprognostic (9.85e-5)"	"unprognostic (4.72e-3)"	"unprognostic (9.44e-3)"	"unprognostic (2.49e-1)"	"unprognostic (1.48e-2)"	"unprognostic (1.25e-3)"	"unprognostic (9.17e-3)"	"unprognostic (1.41e-1)"	"unprognostic (2.80e-1)"	"unprognostic (5.46e-3)"	"unprognostic (6.79e-2)"	"unprognostic (4.18e-2)"	"unprognostic (9.67e-2)"	"unprognostic (1.15e-1)"	"unprognostic (4.78e-2)"	"unprognostic (2.73e-3)"	2.8	3.7	1.0	1.3	1.7	2.5	3.5	4.7	2.1	5.0	0.7	2.1	3.6	2.9	0.5	1.4	6.4	1.1	2.0	1.0	1.4	4.2	5.6	1.9	2.3	1.1	1.0	4.3	6.0	1.3	3.6	0.4	1.1	4.5	0.2	0.9	2.1	1.6	2.6	2.4	3.3	0.2	0.8	3.2	21.6	11.3	1.3	1.1	4.6	0.4	0.4	2.2	3.1	1.8	1.0	3.2	1.3	1.9	0.0	0.6	0.5	0.4	0.1	0.0	0.7	0.0	1.5	1.8	0.3	0.2	0.2	1.1	0.3	0.0	0.1	4.1	6.0	1.1	2.8	10.5	0.6	0.6	4.2	1.7	0.0	0.2	0.3	0.9	0.0	2.5	0.6	4.9	0.0	0.7	1.7	2.1	0.1	0.3	1.0	2.8	0.2	0.9	0.3	0.0	1.6	1.2	2.0	0.7	1.9	0.5	0.5	1.9	1.2	0.9	1.4	1.3	0.8	2.3	1.4	1.8	1.2	2.6	1.1	0.2	0.1	0.1	0.3	0.1	0.2	0.2	0.2	0.0	0.0	0.2	0.3	0.2	0.3	0.3	0.0	0.2	0.3	0.2	1.0	1.7	4.7	2.1	1.0	1.4	1.1	1.0	1.1	0.8	1.3	1.8	3.8	0.0	0.5	0.0	15.5	0.9	3.2	3.1	4.6	21.9	5.1	4.2	2.5	1.5	3.3	5.5	18.8	2.1	8.7	1.6	5.9	1.8	5.9	9.2	13.4	2.8	4.9	3.4	0.1	4.7	0.7	4.7	16.8	5.6	0.0	41.9	2.9	3.0	3.0	32.0	0.1	3.2	4.1	2.4	1.2	11.4	6.5	3.1	1.8	0.0	2.5	5.8	9.2	0.0	0.1	2.9	4.0	3.8	11.2	3.3	10.0	4.7	5.4	14.5	0.0	14.6	4.1	9.1	2.5	3.3	2.0	1.1	6.8	14.2	3.4	2.6
TRIM74	"MGC45440, TRIM50C"	ENSG00000155428	"Tripartite motif containing 74"	Q86UV6	7	72959485-72969466	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"stomach 1: 10.2;testis: 6.6"	"Cell type enhanced"	"Detected in some"		"Microglial cells: 1.9;Respiratory ciliated cells: 2.1;Spermatocytes: 1.1"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HEK 293: 3.8;Hep G2: 2.8"									HPA047843			Approved	Cytosol		NA	NA			"Cluster 37: B-cells - Transcription"	"Cluster 22: Non-specific - Unknown function"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 26: Respiratory epithelial cells - Mucosal defense"	Cytosol		"HPA047843: AB_2680176"	"unprognostic (8.78e-3)"	"unprognostic (3.78e-4)"	"unprognostic (5.84e-3)"	"unprognostic (1.95e-2)"	"unprognostic (1.03e-1)"	"unprognostic (8.26e-2)"	"unprognostic (3.58e-2)"	"unprognostic (1.26e-3)"	"unprognostic (1.65e-2)"	"unprognostic (3.68e-1)"	"unprognostic (8.13e-3)"	"unprognostic (1.98e-2)"	"unprognostic (7.78e-2)"	"unprognostic (7.05e-2)"	"unprognostic (1.67e-1)"	"unprognostic (1.63e-1)"	"unprognostic (1.12e-3)"	0.9	1.6	1.2	0.6	1.4	1.0	1.2	2.5	1.6	1.8	0.8	0.8	1.3	1.2	1.2	0.5	2.5	0.5	0.7	1.3	1.4	1.7	2.6	0.7	1.2	1.5	1.3	1.8	2.5	0.5	1.7	0.1	1.3	1.9	0.3	0.6	0.7	0.5	0.5	0.9	1.3	0.4	1.2	1.2	10.2	6.6	1.2	0.6	1.5	0.2	0.3	0.8	1.2	1.8	0.0	0.1	0.7	0.7	0.2	0.0	0.0	0.4	0.0	0.1	0.2	1.0	0.7	0.5	0.1	0.0	0.2	0.3	0.0	0.0	0.0	0.4	3.8	0.6	0.0	2.8	0.1	1.3	1.6	0.3	0.2	0.0	0.2	0.5	0.0	0.9	0.5	2.2	0.0	1.1	0.4	1.9	0.0	0.0	0.8	0.9	0.3	0.4	1.1	0.4	0.3	0.3	0.4	0.0	0.8	0.1	0.0	0.6	1.4	0.1	0.5	0.2	0.0	1.7	1.4	0.3	0.5	0.7	0.3	0.1	0.0	0.1	0.1	0.0	0.1	0.5	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	1.2	1.4	2.5	1.6	1.3	1.4	1.5	1.3	1.3	1.2	1.2	1.8	0.0	0.0	0.5	0.3	0.0	0.1	0.1	0.5	0.0	0.0	0.0	0.0	0.2	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.0	0.2	0.0	0.0	0.4	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.3	0.5	0.0	0.0	0.0	1.9	0.0	0.0	0.0	0.5	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.1	0.0	0.0	0.0	0.1	1.1	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.1
TUBA3C	"bA408E5.3, TUBA2"	ENSG00000198033	"Tubulin alpha 3c"	P0DPH7	13	19173772-19181824	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	714	"testis: 404.9"	"Group enriched"	"Detected in some"	25	"Early spermatids: 703.3;Late spermatids: 250.4;Spermatocytes: 947.8;Spermatogonia: 255.9"	"Cancer enhanced"	"Detected in many"		"liver cancer: 2.7;testis cancer: 2.7"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	49	"HDLM-2: 107.5;U-2 OS: 256.9;U-266/70: 84.2;U-266/84: 109.7"									"HPA039247, HPA043684, HPA063394"	Uncertain		Supported	Microtubules		NA	Yes				"Cluster 36: Testis - Spermatogenesis"	"Cluster 9: U-2 OS - Unknown function"	"Cluster 66: Spermatocytes - Spermatogenesis"	Microtubules		"HPA039247: AB_2676410, HPA043684: AB_2678617, HPA063394: AB_2685003"	"unprognostic (3.76e-3)"				"unprognostic (1.33e-1)"							"unprognostic (3.00e-1)"		"unprognostic (1.04e-1)"	"unprognostic (1.26e-1)"			0.1	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.5	404.9	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	2.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	2.4	0.0	0.0	0.0	0.0	107.5	0.0	0.0	0.0	0.4	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	1.1	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.5	0.0	0.4	256.9	0.2	0.3	84.2	109.7	0.2	0.1	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	2.7	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	703.3	0.0	0.0	0.7	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	250.4	21.1	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	9.8	0.0	0.0	0.0	0.0	0.0	0.0	13.1	0.0	0.6	947.8	255.9	0.0	0.3	0.0	0.0	0.0	0.0	0.0
UNC5A	"KIAA1976, UNC5H1"	ENSG00000113763	"Unc-5 netrin receptor A"	Q6ZN44	5	176810519-176880898	"Predicted membrane proteins"	Apoptosis	"Developmental protein, Receptor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 30.4;pituitary gland: 14.7"	"Group enriched"	"Detected in some"	4	"Excitatory neurons: 54.4;Inhibitory neurons: 19.4;Muller glia cells: 13.9"	"Cancer enhanced"	"Detected in many"		"ovarian cancer: 7.5"	"Group enriched"	"Detected in many"	6	"amygdala: 10.5;basal ganglia: 15.1;cerebral cortex: 30.4;hippocampal formation: 16.3;white matter: 11.9"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	8	"SCLC-21H: 86.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA071450			Approved	"Plasma membrane,Cytosol"		NA	NA			"Cluster 2: Granulocytes - Unknown function"	"Cluster 10: Brain - Neuronal signaling"	"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	"Plasma membrane, Cytosol"		"HPA071450: AB_2686397"	"unprognostic (5.95e-2)"	"unprognostic (1.15e-1)"	"unprognostic (4.18e-3)"	"prognostic unfavorable (2.23e-4)"	"unprognostic (5.26e-2)"	"unprognostic (2.23e-1)"	"unprognostic (6.66e-3)"	"unprognostic (5.06e-3)"	"unprognostic (3.52e-1)"	"unprognostic (1.36e-1)"	"unprognostic (5.07e-1)"	"unprognostic (9.95e-2)"	"unprognostic (3.77e-5)"	"unprognostic (6.39e-2)"	"unprognostic (2.89e-1)"	"unprognostic (2.27e-1)"	"unprognostic (5.17e-2)"	0.4	7.5	10.5	0.3	15.1	0.4	0.7	2.6	30.4	0.3	0.0	0.1	0.4	0.4	0.2	0.1	0.6	0.2	0.3	16.3	0.0	0.1	0.1	0.3	0.9	0.0	0.0	0.1	1.8	0.0	14.7	0.0	0.0	0.2	0.0	3.1	2.5	0.0	0.0	0.5	0.1	0.1	0.0	0.1	1.0	0.7	0.0	0.1	0.5	0.0	0.0	0.2	0.1	11.9	0.0	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.7	0.0	0.1	0.0	5.4	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	2.3	0.0	0.0	1.4	3.5	0.0	0.0	0.0	2.5	10.1	0.0	86.4	3.9	0.0	0.3	0.0	0.0	0.3	0.3	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.8	0.0	0.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	10.5	15.1	2.6	30.4	16.3	0.0	0.0	0.0	0.0	0.0	0.0	11.9	0.3	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	4.7	0.6	0.3	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.9	0.1	0.9	0.0	0.0	54.4	0.0	0.0	0.0	0.0	1.6	0.0	2.0	0.0	0.0	0.0	5.0	19.4	0.0	0.0	0.0	0.0	3.2	0.0	0.0	0.0	4.7	0.0	13.9	0.0	7.1	2.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.5	0.0	0.0	0.0	0.1	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0
WNK4	PRKWNK4	ENSG00000126562	"WNK lysine deficient protein kinase 4"	Q96J92	17	42780610-42797066	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"	"Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 11.0;kidney: 37.6;prostate: 11.6"	"Cell type enriched"	"Detected in some"	4	"Distal tubular cells: 160.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"fHDF/TERT166: 32.6;K-562: 36.8;TIME: 34.1;WM-115: 23.0"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA016500	Approved					NA	NA				"Cluster 7: Kidney - Transmembrane transport"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 39: Non-specific - Basic cellular processes"			"HPA016500: AB_10962984"	"unprognostic (6.34e-3)"	"unprognostic (1.35e-1)"	"unprognostic (2.15e-1)"	"unprognostic (5.58e-2)"	"unprognostic (1.78e-2)"	"unprognostic (1.96e-1)"	"unprognostic (2.48e-1)"	"unprognostic (1.69e-1)"	"unprognostic (5.84e-2)"	"unprognostic (3.94e-1)"	"unprognostic (2.08e-3)"	"unprognostic (4.33e-3)"	"unprognostic (7.70e-3)"	"unprognostic (1.62e-1)"	"unprognostic (6.11e-2)"	"unprognostic (1.43e-1)"	"unprognostic (7.99e-2)"	1.3	0.0	0.7	1.1	0.9	0.0	2.8	0.8	3.3	0.6	0.3	9.8	1.9	0.2	0.7	8.9	0.4	0.0	0.1	1.7	1.1	37.6	0.2	0.1	0.1	1.1	0.7	4.3	0.2	0.0	1.2	0.0	0.7	11.6	11.0	0.6	1.8	1.1	0.0	0.5	3.7	0.4	0.6	0.1	3.4	0.2	1.0	0.0	0.0	0.3	0.1	0.2	0.4	1.0	2.1	1.2	0.6	0.0	0.7	0.2	4.8	11.9	4.8	4.5	1.3	0.7	1.0	0.6	6.8	32.6	1.2	0.0	0.2	0.3	8.6	0.6	1.8	0.1	0.0	4.7	7.4	0.3	0.7	3.9	1.4	6.4	2.1	2.1	0.3	0.4	36.8	1.3	0.0	1.0	0.0	1.1	0.3	2.0	8.2	0.6	1.2	0.0	0.0	0.5	0.0	0.2	0.1	0.2	1.7	4.1	2.4	2.7	34.1	0.3	3.1	0.5	0.4	6.2	5.3	1.2	0.0	2.1	23.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.9	0.8	3.3	1.7	1.1	1.1	0.7	0.7	0.6	1.0	1.0	0.2	0.0	0.6	0.0	0.5	0.0	0.2	0.0	0.6	0.2	7.1	4.1	1.0	1.5	0.6	7.3	0.0	0.0	0.3	8.0	160.4	0.0	0.0	5.1	1.1	0.2	13.1	0.0	0.2	0.2	0.2	0.1	3.1	6.7	4.5	0.1	0.7	0.0	0.0	0.0	0.2	40.1	0.0	0.3	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	3.2	0.4	0.0	3.6	0.9	1.0	2.9	0.5	0.0	0.2	0.5	0.8	0.8	12.1	0.4	0.0	0.2	0.0	13.1	0.3